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INTRODUCTION: Individuals with type 1 diabetes (DM1) have a 14-40% greater risk of 
fractures at all ages. The etiology of greater fracture risk is not known, but possibly related to 
alterations in bone size, density and micro architecture. Childhood and early adolescent growth 
years are the best time to optimize the effects of physical activity (PA) on bone development. My 
primary objective was to compare bone size, density, and micro-architecture at the distal radius 
and tibia between children with DM1 and typically-developing children (TDC). My secondary 
objective was to explore the role of daily minutes of moderate-to-vigorous PA (MVPA), 
vigorous PA (VPA), and daily impacts on bone outcomes that differed between children with 
DM1 and TDC.  
METHODS: Using a cross-sectional design, I analyzed data from 68 children (mean age 11.3, 
SD 1.9y), categorized into DM1 group (N=21) and TDC group (N=47). High-resolution 
peripheral quantitative computed tomography (HR-pQCT) measured bone size, density, and 
micro-architecture at dominant side distal radius and tibia and pQCT measured forearm and 
lower leg muscle area. Triaxial accelerometers recorded daily minutes of MVPA, VPA, and daily 
impact counts ≥3.9g. Site-specific MANCOVAs and pairwise comparisons (Bonferroni) 
assessed group differences (Pillai’s trace) and β-coefficients assessed role of PA. Base models 
were adjusted for sex, maturity, site-specific muscle area, and BMI z-score. Significance set at 
p<0.05. 
RESULTS: Bone properties differed between groups at the radius (F(18,42)=7.59, p<0.001) and 
tibia (F(18,42)=2.83, p=0.003). DM1 had lower total area, greater total and cortical densities, 
greater cortical thickness, lower cortical porosity, pore volume, pore diameter, trabecular area 
and number, and greater trabecular separation at radius. DM1 had lower cortical porosity, pore 
volume, pore diameter at tibia. VPA was an independent predictor of cortical pore diameter at 
the radius (Std. β=-0.18). Significance p<0.05. 
CONCLUSIONS: Children with DM1 had deficits in total bone size, greater total and cortical 
densities, and alterations in cortical and trabecular micro-architecture at the radius, as well as 
alterations in cortical micro-architecture at the tibia. VPA independently predicted cortical pore 
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Type 1 diabetes mellitus (DM1) is a chronic disease characterized by an insulin deficiency 
caused by auto-immune pancreatic β-cell destruction (Weber, Haynes, Leonard et al., 2015). 
Individuals with DM1 also have a 14% greater risk of fractures during childhood and a 40% 
greater risk of fractures during older age (Weber et al., 2015). The underlying reasons for this 
greater fracture risk in individuals with DM1 are multifactorial and poorly understood (Weber et 
al., 2015), but likely related to challenges in bone development, evidenced by a smaller cross-
sectional area and lower trabecular bone density at the radius and tibia in children and youth with 
DM1 (Bechtold, Putzker, Bonfig et al., 2007; Maratova, Soucek, Matyskova et al., 2018; Moyer-
Mileur, Dixon, Quick et al., 2004; Roggen, Gies, Vanbesien et al., 2013; Saha, Sievanen, Salo et 
al., 2009). These findings suggest an unfavourable bone macro-structure for resisting fractures, 
however much less is known about potential differences in cortical and trabecular bone micro-
architecture. Importantly, there is a “window of opportunity” to optimize improvements in bone 
size when long bone growth accelerates in adolescence (Turner & Robling, 2003). As such, 
acquiring information of bone micro-architecture in children and youth with DM1 may prove to 
be of critical importance for identifying underlying skeletal deficits that may contribute to higher 
fracture rates of individuals with DM1. 
Children and adolescents with DM1 have been observed to have lower levels of physical 
activity (PA) than their typically-developing peers (de Lima, Mascarenhas, Decimo et al., 2017; 
Michaliszyn & Faulkner, 2010; Valerio, Spagnuolo, Lombardi et al., 2007). Longer daily times 
spent in moderate-to-vigorous PA (MVPA), vigorous PA (VPA), and a greater number of daily 
impacts are reported to contribute to the development of a stronger bone structure in typically-





Nettlefold et al., 2017c; Janz, Letuchy, Burns et al., 2014; Kehrig, Bjorkman, Muhajarine et al., 
2018); however, the role of PA on bone micro-architecture, particularly cortical bone micro-
architecture, has not been assessed in cohorts including children with DM1. This information is 
necessary to guide the development of PA therapies aimed at optimizing the development of 
bone size, density, and micro-architecture in children and contributing to a lifelong reduction in 
rates of bone fractures in both children and youth with DM1 and TDC. 
My thesis provides new information of the differences in cortical bone micro-architecture 
in children and youth with DM1 and explores the independent role of PA on bone size, density, 
and cortical and trabecular bone micro-architecture in children and youth with DM1 and TDC. 
This information may further our understanding of what underpins the mechanism of higher 
fracture risk in children and youth with DM1 and may help to identify PA as a treatment option 
to reduce lifelong fracture risk in children and youth with DM1 and TDC.  
 
2 LITERATURE REVIEW 
In this chapter, I will review the clinical problem of bone fragility in individuals with DM1 and 
higher fracture rates in children with DM1. I will focus on six key areas: 1. Imaging pediatric 
bone; 2. Longitudinal changes in children with DM1 and cross-sectional literature assessing bone 
structure and density in children and youth with DM1; 3. Bone micro-architecture in children 
and youth, and adults with DM1; 4. Physiological mechanisms underlying bone fragility in 
individuals with DM1; 5. Theoretical bases of bone adaptation to loading; 6. The role of PA on 






2.1 Imaging and Assessing Pediatric Bone 
Advancements in technology have substantially improved our ability to assess different 
characteristics of bone. Here, I will provide a critical review of the clinical and research tools 
commonly used to image or assess bone in children, including dual-energy x-ray absorptiometry 
(DXA), qualitative ultrasound (QUS), magnetic resonance imaging (MRI), peripheral 
quantitative computed tomography (pQCT), and high-resolution pQCT (HR-pQCT).  
2.1.1 Imaging Pediatric Bone Using DXA 
DXA is the standard clinical method for predicting hip and vertebral fracture risk in at-risk 
populations, such as post-menopausal women (Cummings, Bates, & Black, 2002), and is the 
standard clinical tool used to measure bone in pediatrics. However, despite the common use of 
DXA in clinical and research settings, this tool is not ideal for imaging bones in children for 
several reasons. First, while one of the distinct advantages of DXA is its ability to image the 
whole body, and sites such as the femoral neck and lumbar spine, this carries with it, a higher 
radiation exposure than previously mentioned imaging tools (~5mSv for whole-body, hip, and 
lumbar spine DXA in children) (National Osteoporosis Society, 2004). Second, forearm fractures 
account for roughly 40% of all pediatric fractures (Mokawem & Scott, 2015), therefore have 
more clinical relevance than DXA measurements of the total body, the hip, or the lumbar spine. 
Third, DXA is a planar imaging tool that cannot assess 3D bone structure or true volumetric 
density values. For this reason, DXA density outcomes are specified as areal (aBMD), instead of 
volumetric (vBMD) (Bolotin & Sievanen, 2001). This is especially a problem in children, as 
DXA-derived aBMD is influenced by bone size and is artificially higher in individuals with 





±20% of the error in aBMD to differences in beam absorption characteristics of other tissues 
such as fat, muscle, and marrow surrounding or inside bone (Bolotin & Sievanen, 2001). 
2.1.2 Imaging Pediatric Bone Using QUS and MRI 
QUS is safe (no radiation), portable, easy to use, and can be used to assess bones at common 
fracture regions at the wrist, making this an attractive tool for researchers assessing bone in a 
pediatric population (Baroncelli, 2008). Despite these advantages, there is a general scepticism 
of findings from studies using QUS to assess bone. First, QUS cannot directly measure BMD, 
instead it measures the speed of sound (SOS) through bone tissue, which is used as a surrogate 
measurement of bone mineral quality. Second, this tool is limited by using different variables to 
estimate bone mineral quality across a large variety of QUS devices (Baroncelli, 2008), therefore 
limiting the external validity of QUS findings to particular devices. Third, there is still a poor 
level of knowledge on the physical mechanisms surrounding QUS measurement of bone 
(Baroncelli, 2008). This is further complicated by different levels of bone mineralization in 
pediatric bone tissue affecting QUS outcomes designed to measure fully mineralized bone. 
Lastly, QUS is not an imaging tool so it cannot be used to assess bone structure, and there is 
difficulty comparing these results to x-ray based densitometric techniques (Baroncelli, 2008). 
Similar to ultrasound, MRI uses no radiation. Instead, MRI maps the location of 
hydrogen atoms in the body, mostly present in water and fat in the body, and uses this 
information to measure contrasts in tissue properties (Majumdar, Genant, Grampp et al., 1997). 
For this reason, MRI is most applicable for measuring properties of soft tissue, and less 
commonly, bone. However, MRI can still be used to capture 3D-images of bone and assess 
trabecular bone micro-structure (Chen, Shepherd, McMillan et al., 2019; Majumdar et al., 1997). 





assess cortical bone micro-architecture (Majumdar et al., 1997). This is a notable limitation as no 
previous studies have assessed cortical micro-architecture in children with DM1, which may be a 
critical determinant of bone strength, as previous studies have found that cortical thickness, 
measured using pQCT, predicts 72% of the variance in bone failure load based on mechanical 
testing at the radius shaft (Muller, Mitton, Moilanen et al., 2008). 
2.1.3 Imaging Pediatric Bone Using pQCT, and HR-pQCT 
pQCT is another common tool used to measure volumetric BMD, 3D bone macro-structure and 
estimate bone strength at distal and shaft sites at the radius and tibia (200-800μm voxel size) 
(Figure 1). One of the benefits of this low radiation dose tool is that it offers another important 
application for its use musculoskeletal research, by being able to measure muscle area at the 
forearm and lower leg (Björkman, Duff, Frank-Wilson et al., 2017). As with most x-ray-based 
imaging techniques, pQCT scans are susceptible to motion artefacts. This can prove challenging 
in pediatric populations as children must stay relatively motionless for several minutes during 
scans. 







With further technological advancements, came improvements in imaging resolutions and 
the ability to assess bone micro-architecture using QCT. The higher resolution of the HR-pQCT 
(82μm voxel size) allows researchers to assess both cortical and trabecular micro-architecture 
after separating cortical and trabecular bone compartments (Figure 2) (Kawalilak, Bunyamin, 
Bjorkman et al., 2017). HR-pQCT has also been validated for its use in adults against gold 
standard measurements of bone micro-architecture (micro-CT) in cadavers (Boyd, 2008; Laib & 
Ruegsegger, 1999). However, there are still several limitations of using HR-pQCT to assess bone 
micro-architecture in children. First, the accuracy of this tool has not been validated against 
micro-CT in a child population, as this would require micro-CT imaging of bone samples 
obtained from child cadavers. However, the measurement error in children has been recently 
determined in our lab (Bunyamin, Bjorkman, Kawalilak et al., 2019). Second, the 82μm voxel 
size is very close to the low end of trabecular thicknesses at the distal tibia (D. Liu, Burrows, 
Egeli et al., 2010) and would only be able to capture larger cortical pores >82μm in adults 
(Patsch, Burghardt, Kazakia et al., 2011). These structures are even smaller in children, and it 
follows that researchers may need to develop a tool with an even higher resolution for pediatric 
bone assessment. There has been recent progress in improving the spatial resolution of this tool, 
as the manufacturers of the Xtreme CT have recently developed a second generation of this tool 
(Xtreme CT II) capable of measuring bone using a 60μm voxel size, however despite 
improvements in spatial resolution, large voxel size remains a limitation in imaging smaller 
structures in bone. Third, while certain micro-architectural outcomes such as trabecular number 
are truly 3D and derived from distance transformations – determined by the average diameter of 
spheres between trabecular ridges, other outcomes such as trabecular thickness and separation, 





Liu, Zhang, Sekhon et al., 2010) and were validated in an adult population. However, indirect 
measurement of bone micro-architectural outcomes are not unique to HR-pQCT, as similar 
methods are used to derive trabecular micro-architecture outcomes using micro-MRI (Majumdar 
et al., 1997). HR-pQCT is widely considered an excellent, and clinically-relevant tool for 
measuring bone characteristics relevant to bone fractures, as evident from a recent prospective 
study that found that cortical and trabecular micro-architecture outcomes were associated with 
fracture risk in older men and women, independent of DXA-measured aBMD (Samelson, Broe, 
Xu et al., 2019). Whereas in children, there is evidence of associations between HR-pQCT bone 
outcomes and low-energy fractures in boys and girls (Määttä, Macdonald, Mulpuri et al., 2015; 
Macdonald, Maatta, Gabel et al., 2018). However, as HR-pQCT was designed and validated for 
use in adults, we must remain cautious in our interpretation of these findings in children and 
youth. 
Figure 2. High-resolution peripheral computed tomography (HR-pQCT) scan illustrating the 
separation of cortical bone (blue) and trabecular bone (green), and the cortical porosity (grey) at 








2.2 Bone Macro-Structure and Density in Children and Youth with DM1 
2.2.1 Longitudinal Changes in Children with DM1 Compared to Predicted Changes 
in a TDC Reference Population 
Findings from two studies using pQCT to measure bone macro-structure and density report 
deficits in cortical bone area, density, and thickness, as well as trabecular bone area, content, and 
density in children with DM1 (Table 1). One of these studies reported skeletal deficits in a group 
of children with DM1 compared to normative data, z-scores, and predicted changes in TDC at 
distal and shaft sites at the radius using pQCT (Bechtold et al., 2007), while the other study 
reported deficits in a group of children with DM1 compared against predicted annual changes of 
a regional reference population at distal and shaft sites at the tibia using pQCT (Moyer-Mileur et 
al., 2004). When compared to reference data, baseline measurements of children (mean 
age=9.9y) suggested that children with DM1 had a lower trabecular density at the distal radius 
and a lower total and cortical cross-sectional area, and cortical BMD at the radius shaft (Bechtold 
et al., 2007). It is important to note that these differences normalized and were not longer present 
after 5.5 years (mean age=15.4y). Moyer-Mileur et al. (2004) found similar deficits in bone size 
outcomes at the distal tibia, as well as an 8.6% lower torsional bone strength in children with 
DM1. Adolescents in the DM1 group had a lower cortical area (-7.6%), cortical content (-6.9%), 
cortical thickness (-4.9%), trabecular area (-5.1%), trabecular content (-10.9%), and trabecular 
density (-5.9%) at baseline and similar deficits at the 12-month follow-up (Moyer-Mileur et al., 
2004). After 12 months, there were increases in cortical bone properties in both groups; however, 
increases in bone area, content, density, and estimated torsional bone strength were lower in the 





2.2.2 Cross-Sectional Evidence 
Cross-sectional studies reported similar deficits in total and trabecular bone size and densities, as 
well as lower cortical areas and thicknesses, and greater cortical densities (Table 1). Maratova et 
al. (2018) reported that children with DM1 had a greater cortical density, along with a lower 
trabecular density, cortical thickness, and torsional bone strength at the tibia. There were no 
significant differences in total and cortical cross-sectional bone area between children with DM1 
and TDC (Maratova et al., 2018). Other researchers have suggested that DM1 is associated with 
a smaller cortical area in boys at the radius (-12% lower in boys) and in boys and girls at the tibia 
(-4% lower in girls and -9% lower in boys), and a lower trabecular density (-4% girls, -5% boys) 
at the distal tibia (Saha et al., 2009). They also reported that children with DM1 had a lower 
torsional bone strength at the radius (-5% girls, -17% boys) and tibia shaft (-7% girls, 12% boys) 
compared to TDC (Saha et al., 2009). Roggen et al. (2013) investigated differences between 
older adolescents and young adults with DM1. They reported a lower total cross-sectional area at 
the radius in males (-5.6%) and females (-15.6%), but no differences in trabecular density at the 
radius (Roggen et al., 2013). Other cross-sectional studies report similar findings of lower 
trabecular bone density in boys and girls with DM1 (Heap, Murray, Miller et al., 2004; Lettgen, 
Hauffa, Mohlmann et al., 1995). Both studies reported a lower trabecular bone density in 
adolescents (-3.8%) (Heap et al., 2004) and children (-18.9%) with DM1 (Lettgen et al., 1995). 
Findings using digitalized X-rays at the second metacarpal support previous findings of smaller, 
and weaker bones children with DM1 (Franceschi, Longhi, Cauvin et al., 2017), however these 
findings are based on measurements obtained using planar imaging tools, which do not offer the 






2.3 Bone Micro-Architecture in DM1 
2.3.1 Bone Micro-Architecture in Children and Youth with DM1  
There is no evidence of differences in cortical micro-architecture and limited evidence of 
differences in trabecular micro-architecture between children and youth with DM1 and TDC 
(Table 1). Findings from one study using MRI to measure bone micro-architecture, reported that 
children with DM1 have a lower trabecular volume, trabecular number, and higher trabecular 
separation than their typically-developing peers (Chen et al., 2019). However, MRI is unable to 
assess cortical bone micro-architecture, which is a crucial determinant of overall bone strength 
(Muller et al., 2008; Nishiyama, Macdonald, Moore et al., 2012). No studies have assessed 
cortical bone micro-architecture in children and youth with DM1, as this measurement requires 
HR-pQCT. Obtaining HR-pQCT scans in children with DM1 would provide new evidence of 
cortical bone micro-architecture and add to current evidence of deficits in trabecular micro-
architecture in children and youth with DM1, which may help us to reveal the origins of bone 
fragility in childhood.  
2.3.2 Bone Micro-Architecture in Adults with DM1 
Evidence of differences in bone size, density, and cortical and trabecular micro-architecture as 
measured by HR-pQCT are only reported in adults with DM1 (Shanbhogue, Hansen, Frost et al., 
2015). They found that adults with DM1 and the presence of microvascular disease had deficits 
in total BMD (-10%, -17%), trabecular BMD (-18%, -20%), trabecular thickness (-12%, -14%), 
bone stiffness (-14%, -16% ), and failure load (-14%, -15%) at the distal radius and tibia, 
respectively; and additional deficits in cortical area (-15%), trabecular bone-volume ratio (-20%), 
as well as a greater trabecular separation (+12%) and heterogeneity (+19%) at the distal tibia 





2015). Independent of the presence of microvascular disease, all adults with DM1 had a larger 
total area (+13%) and trabecular area (+18%), as well as a lower total density (-11%), cortical 
density (–3%), and cortical thickness (–8%) at the distal radius compared to adults without DM1. 
They reported no differences between the DM1 and control group at the distal tibia (Shanbhogue 
et al., 2015).  
 
2.4 Physiological Mechanisms Underlying Bone Fragility in Individuals with DM1 
It is important to discuss the physiological mechanisms underlying bone fragility in DM1, as 
evidence has suggested it is a condition of low bone turnover (Hygum, Starup-Linde, Harslof et 
al., 2017; Napoli, Chandran, Pierroz et al., 2017). The mechanisms underlying bone fragility in 
DM1 are complex and may be related to hyperglycaemia, oxidative stress and the accumulation 
of advanced glycation end-products (AGEs) that compromise collagen properties, increased 
marrow adiposity, release of inflammatory factors and adipokines from visceral fat (Napoli et al., 
2017). Most of the recent studies assessed in a systematic review have indicated lower levels of 
bone turnover markers, and a lower activation frequency of bone remodelling units in adults with 
DM1 (Hygum et al., 2017). Smaller cross-sectional bone areas at the radius or tibia show 
associations with poor glycemic control (↑ HbA1c), lower IGF-1, insulin, lower levels of vitamin 
D (Napoli et al., 2017). Glycemic control may prove to be a factor influencing bone fragility, as 
there was a higher degree of trabecular bone mineralization in iliac crest bone biopsies of 
fracturing adults with DM1 compared to non-fracturing adults with DM1. They also found that 
the degree of non-enzymatic collagen cross-linking was higher in fracturing adults with DM1 
compared to adults without DM1 (Farlay, Armas, Gineyts et al., 2016). Degree of trabecular 





HbA1c levels (i.e. higher bone mineralization and lower bone turnover state) (Farlay et al., 
2016). They suggest that excess glucose in the blood contributes to a higher bone mineralization 
rate and the lower remodelling rate allows bone to be further mineralized before being replaced, 
resulting in a less flexible; and more rigid bone matrix, susceptible to low-energy fractures 
(Farlay et al., 2016). 
 
2.5 Bone Structure Adaptation to Loading Daily Physical Activity and Impacts and Bone 
Structure 
2.5.1 Theoretical Bases of Bone Adaptation to Loading 
The underlying principle highlighting the influence of mechanical loading on bone adaptation is 
known as the mechanostat hypothesis (Frost, 1987). According to the mechanostat hypothesis, 
bone modeling and remodelling processes are guided by mechanisms sensing the elastic 
deformation of bone (Frost, 1987). These bone adaptations are site-specific and as the result of 
loads generated both internally, through muscle forces; and externally, through external reaction 
forces such as impacts (Schoenau & Frost, 2002). It is important to note that the mechanical 
loads applied to bone are different than bone strain; however, they are interconnected. 
Mechanical loads induce stress on load-bearing bones, thereby causing a material strain on bone 
tissue (Al Nazer, Lanovaz, Kawalilak et al., 2012). Bone strain is the governing stimuli for the 
bone remodelling process and can be defined as the deformation of bone through the relative 
displacement of the particles that make-up bone (Al Nazer et al., 2012). Osteocytes can sense 
bone strain and guide bone adaptation through cell signalling. These signals are sent to other 
bone cells; namely osteoblasts and osteoclasts, to begin the bone remodelling process through 





development, bone modelling occurs which allows bone to grow in length, and in width, through 
the formation of new bone on the outer surface (Binkley et al., 2008). The degree of bone 
modelling is in part, determined by genetics, but also by the strains that bone is exposed to 
(Binkley et al., 2008). This presents us with a window of opportunity during peak bone growth in 
which we may use PA to optimize adaptations of bone that carry into adulthood (Turner & 
Robling, 2003).  
2.5.2 Using Accelerometers to Estimate Bone Loading in Children and Youth 
Using wearable accelerometers, we are able to record daily minutes of MVPA and VPA (Kehrig, 
Bjorkman, Muhajarine et al., 2019; Trost, Loprinzi, Moore et al., 2011) and daily number of 
impacts in children and youth (Kehrig et al., 2019). It is not possible to measure principle bone 
strains directly, as the axes of the forces causing this strain are not known and change with 
different movements (Al Nazer et al., 2012). A close approximation to this would require 
multiple strain gauges to be fitted to different regions of exposed bone directly in line with the 
forces being generated (Al Nazer et al., 2012), which is not realistic for child populations. 
However, it is possible to measure the mechanical bone loading causing bone strain by 
measuring ground reaction forces (GRF) in children (Meyer, Ernst, Schott et al., 2015). A 
distinct drawback to this method is that you can only able to obtain a “snapshot” of the GRF 
using force plates, which does not allow researchers to estimate daily average levels of bone 
loading. Instead, accelerometers may be used to record daily levels of PA as an estimate of bone 
loading (Meyer et al., 2015). Accelerometer activity counts were originally validated against 
estimates of VO² max in children (Evenson, Catellier, Gill et al., 2008; Trost et al., 2011), 
however, they are correlated with mechanical loading, as measured by GRF in children. Activity 





correlated to mean GRF (r=0.90) in ActiGraph GT3X accelerometers in children, however it is 
important to note that the accelerometers used in this study consistently overestimated GRF 
(Meyer et al., 2015). 
2.5.3 MVPA, VPA, and Impacts and Bone Size, Density, and Micro-Architecture in 
Children and Youth 
Previous research indicates a beneficial relationship between MVPA, VPA, and impacts, and 
trabecular and cortical micro-architecture in TDC, but evidence of these relationships in children 
and youth with DM1 is limited. Longitudinal findings from Gabel et al. (2017c) reported that 
MVPA positively predicted trabecular bone volume fraction and failure load at the radius, as 
well as total area, cortical porosity, trabecular bone volume fraction, and estimated bone failure 
load at the tibia (Gabel et al., 2017c). Gabel et al. (2017b) also reported that the volume and 
frequency of VPA was positively associated with bone failure load at the tibia. Children in the 
upper quartile of VPA bout frequency had a greater bone failure load (+10%) at the tibia across 
adolescent years than children in the lowest quartile of VPA bout frequency (Gabel et al., 
2017b). Results from my previous work also provided evidence of the benefits of MVPA and 
VPA in TDC. We reported that average daily minutes of MVPA and VPA independently 
predicted the variance in bone strength at the tibia, but not at the radius (Kehrig et al., 2019). Our 
findings also showed that impact counts greater than or equal to 3.9g (1g = 9.81 m/s2) exhibited a 
positive relationship with tibia bone strength in TDC (Kehrig et al., 2019) 
There is no evidence of a relationship between objectively-measured PA and cortical and 
trabecular micro-architecture in children and youth with DM1 in previous literature. However, an 
RCT investigating the role of exercise on DXA-measured aBMD in children with DM1 found a 





with DM1 and TDC (Maggio, Rizzoli, Marchand et al., 2012). Their results suggest that there 
was no difference in bone adaptation to PA in children and youth with DM1 (Maggio et al., 
2012).  
2.5.4 Mechanical Loading Adaptations in a DM1 Animal Model 
Evidence from DM1 mouse models have suggested that hyperglycemia may lead to impairments 
in bone’s adaption to mechanical loading (Parajuli, Liu, Li et al., 2015). They observed positive 
differences in cortical bone area (+14%, +16%, +6.5%) and cortical bone thickness (11%, +10%, 
+6.5%) between the loaded and non-loaded ulna assessed using bone histomorphometry in male 
and female wild-type mice (control models) and female Akita mice (mild diabetes model). 
Whereas, male Akita mice (severe diabetes model) saw no differences between their loaded and 
non-loaded ulna (Parajuli et al., 2015). It is important to note that findings from mature animal 
models may not reflect adaptations in immature human bone. Instead, these findings warrant 
further investigation of the role of PA and bone characteristics in diabetic populations. 
16 
 
Table 1. Previous literature reporting differences between children and youth with type 1 diabetes (DM1) and typically developing 






Participants Bone Imaging Results 








41 boys and 
girls (mean 
9.87, SD 2.3y) 
with DM1  
pQCT at distal 
and shaft sites 
of radius 
At baseline, distal site, trabecular density was higher in 
DM1 than in TDC, irrespective of age, sex, and Tanner 
stage. At the shaft, DM1 had significantly reduced total, 
cortical, and medullary area as well as cortical density at 
first measurement 
 
After 5.5 years, these parameters had normalized. SSI and 
muscle area were not different from reference population 





with DM1 and 
26 controls 
(13.8y) 
DXA and MRI 
at proximal end 
of tibia  
DM1 had lower trabecular volume, trabecular number, 
and higher trabecular separation than controls 
 
Bone formation (assessed by bone-specific alkaline 




96 boys and 
girls (mean 
10.5, SD 3.1y) 
with DM1 
Digitalized X-
rays at 2nd 
metacarpal and 
QUS at distal 
phalanges 
Outer diameter, inner diameter, cortical area, and 
medullary area were smaller in DM1 than in controls. 
BBRI (an index of bone strength) was lower compared to 
the normal values. Speed of sound (SOS) was higher in 
DM1, while bone transmission time (BTT) was not 
different 
 
Inner diameter and medullary area were smaller in Low 
HbA1c compared to High HbA1c, but not in outer 
diameter, cortical area, metacarpal index, and BBRI. No 
difference between Low HbA1c and High HbA1c was 








(12 to 17y) with 
DM1 and 95 
TDC 
DXA and 
pQCT at distal 
and shaft sites 
of tibia 
DM1 group had lower trabecular density at the tibia (-
3.8%) compared to controls. Lower femoral neck aBMD 
(-7.8%) and BMAD (-7.3%), and whole-body BMC (-
6.9%), aBMD (-4.9%), BMAD (-3.4%), and whole-body 
BMC in relation to height (-6.2%) or lean mass (-8.8%) 
compared to controls 
 




21 children and 
adolescents 




pQCT DM1 group had lower trabecular bone density (-18.9%), 
while total bone density and cortical bone density were 
not significantly lower 
Maggio 2010 Cross-
sectional 
27 children with 
DM1 and 32 
controls (mean 
10.5, SD 2.5y) 
DXA aBMD results were similar among DM1 and healthy 
subjects. Proportion of children with low aBMD was 
identical in both groups 







27 children with 
DM1 and 32 
controls (mean 
10.5, SD 2.5y) 
DXA The intervention had a moderate to large effect on LBM 
but not on other anthropometry variables. TB and LS2–
LS4 aBMD changes were higher in both intervention 
groups. Changes during the exercise intervention were 




(mean 16.2, SD 
1.2y) with DM1 
pQCT at distal 
and shaft sites 
of tibia 
DM1 had greater cortical density and lower cortical 
thickness, trabecular density, and SSI compared to the 
reference. Total and cortical bone areas at the tibia shaft 
















42 children with 
DM1 and 199 
controls (12 to 
18y) 
DXA and 
pQCT at distal 
and shaft sites 
of tibia 
At baseline, DM1 had lower tibia cortical area (-7.6%), 
content (-6.9%), and thickness (-4.9%), trabecular area (-
5.1%), content (-10.9%), and density (-5.9%), SSI (-
8.6%), lumbar spine BA (-6.6%), BMC (-11.9%), aBMD 
(-4.9%), BMAD (-1.3%), and whole body BA (-2.1%), 
and BMC (-8.3%). DM1 had slightly higher cortical 
density (0.8%), but difference disappeared at 12 months 
 
After 12 months, tibia cortical bone characteristics 
increased in both groups; however, lower gains for 
cortical area, content, density, and SSI were observed in 
subjects with DM1. Tibia trabecular bone values 







18.1y and males 





pQCT at distal 
radius 
Male and female DM1 patients had a smaller total radius 
area (-5.6%, and -15.6%, respectively). Similar radius 















and males 15.9)  
DXA and 
pQCT at distal 
and shaft sites 
of radius and 
tibia  
No difference between DM1 and TDC at distal radius  
 
At radius shaft, DM1 group had lower total bone content, 
cortical area, cortical content, and SSIp. At distal tibia, 
DM1 group had lower total bone area, content, cortical 
area, and trabecular density. At tibia shaft, DM1 group 
had lower total bone content, cortical area, and SSIp 
 
BMC 2-14% lower in DM1 group at all skeletal sites, 
including the proximal femur and lumbar spine 
 
Among diabetic boys, the mean deficit in BMC 
calculated from all measured skeletal sites was more than 
10%, while among the girls it was less than 5%. 
Diabetes-associated deficit seemed to affect boys more 
than girls 










pQCT at distal 
and shaft sites 
of tibia 
All children with DM1 had a lower cortical bone density 
compared to a TDC reference population. Both good and 
bad glycemic control groups had lower trabecular density 
Abbreviations: aBMD = areal bone mineral density, BA = bone area, BBRI = bending breaking resistance index, BMAD = bone 
mineral apparent density, BMC = bone mineral content, BTT = bone transmission time, LS = lumbar spine, QUS = qualitative 




3 OBJECTIVES AND HYPOTHESES 
3.1 Research Objectives 
3.1.1 Primary Research Objective 
The primary objective of my thesis was to compare bone size, density, and cortical and 
trabecular micro-architecture at the distal radius and tibia between children with DM1 and TDC 
after adjusting for covariates.  
3.1.2 Secondary Research Objective 
The secondary objective of my thesis was to explore the role of daily minutes of MVPA, VPA, 
and daily impacts on bone outcomes that differed between children with DM1 and TDC. 
 
3.2 Hypotheses 
3.2.1 Hypothesis for Primary Research Objective 
For my primary objective, I hypothesized there will be differences in bone size, density, and 
cortical and trabecular micro-architecture at the distal radius and tibia between children with 
DM1 and TDC.  
3.2.2 Hypothesis for Secondary Research Objective 
For my secondary objective, I hypothesized daily minutes of MVPA, VPA, and daily impacts 






4.1 Study Design and Participants 
I used a cross-sectional study design. I assessed data from 21 children with DM1 (12 girls, mean 
age 12.1, SD 2.1y) and 47 TDC (22 girls, 10.9, 1.6y) (Figure 3). We recruited 38 children with 
DM1 from LiveWell diabetes clinics, the D-camp at Christopher Lake, SK, and diabetes family 
days in Saskatoon and Regina, SK. In addition, I had access to previously collected data from a 
cohort of 170 TDC recruited from schools and community programs in Saskatoon, Canada 
(Bunyamin et al., 2019). To be included in my thesis analyses, participants had to have valid HR-
pQCT data at the radius or tibia, a valid triaxial accelerometer recording of physical activity and 
impact counts, and valid pQCT data at the forearm or lower leg. I will provide a detailed 
definition of how I determined the validity of my data for each of these tools later in this chapter. 
We also obtained informed assent from our participants and consent from their parents or 






Figure 3. Participant inclusion flowchart. 
 
 
4.2 Anthropometrics, Nutrition and Other Background Characteristics 
We measured anthropometric variables such as height, sitting height, body mass, ulna and tibia 
lengths following previously described methodology (Duff, Björkman, Kawalilak et al., 2017). I 
measured height, sitting height, and limb lengths three times and used the median value in my 
analyses. Maturity was assessed by estimating the years from age at peak height velocity (aPHV) 
for each participant using sex-specific equations (Moore, McKay, Macdonald et al., 2015). 
Estimating somatic maturity allowed me to account for differences in maturation timepoints of 
boys and girls (Gabel, Macdonald, & McKay, 2017a). Body mass indexes (BMI, kg/m²), BMI z-





BMI Group Calculator available on the Centers for Disease Control and Prevention (CDC) 
website. Reference data for this tool was obtained from CDC growth charts from the year 2000 
(Kuczmarski, Ogden, Grummer-Strawn et al., 2000). BMI z-scores are commonly used in child 
populations as a measure of relative body size adjusting for the age and sex. Another technician 
and I assessed daily average dietary protein (g/day), calcium intake (mg/day), and vitamin D 
intake (IU/day) using self-reported data collected from a food-frequency questionnaire (Block 
98, Nutrition Quest). The validity and reliability of this questionnaire has been previously 
assessed in adults (Boucher, Cotterchio, Kreiger et al., 2006). I also obtained age at DM1 
diagnosis (years), years since DM1 diagnosis (years), and averaged long-term blood glucose 
levels (HbA1c, %) of each child from electronic medical records after receiving approval from 
the Saskatchewan Health Authority. 
 
4.3 Bone Size, Density, and Cortical and Trabecular Micro-Architecture 
Two trained technicians obtained scans at the dominant distal radius (7% ulna length) and tibia 
(8% length) using HR-pQCT (Xtreme CT) and followed our validated protocols (Bunyamin et 
al., 2019; Kawalilak et al., 2017). If motion artefacts were present, the technician took a second 
scan at the same site. Each image was graded based on a 5-point scale defined by the 
manufacturer (Pialat, Burghardt, Sode et al., 2012). Scans graded 4 or 5 or scans that the 
software was unable to analyze (both mainly due to excessive patient movement), were 
determined to be invalid and excluded from analyses. We used the manufacturer’s software to 
trace the outer boundary of the bone and manually corrected any errors in the tracing that did not 
match the outer bone boundary to obtain standard evaluation outcomes. Standard evaluation 





Tb.BMD, mg HA/cm³), trabecular bone volume fraction (BV/TV, %) (the ratio of trabecular 
bone volume to total bone volume in the region of interest), trabecular number (Tb.N, 1/mm), 
trabecular thickness (Tb.Th, μm), trabecular separation (Tb.Sp, μm), and trabecular 
heterogeneity (Tb.Sp.SD, μm). 
 Another trained technician and I then used an automated segmentation algorithm to trace 
an inner cortical boundary between the cortical and trabecular bone compartments, and manually 
corrected any errors in the tracing, to separate the cortical bone region before analyzing scans 
with advanced cortical analysis (Burghardt, Issever, Schwartz et al., 2010). Advanced cortical 
analysis outcomes include: total and cortical bone area (Tt.A and Ct.Ar, mm²), cortical total 
volume (Ct.TV, mm³), cortical bone volume (Ct.BV, mm³), cortical bone mineral density 
(Ct.BMD, mg HA/cm³), cortical tissue mineral density (Ct.TMD, mg HA/cm³), apparent cortical 
thickness (Apparent Ct.Th, μm), fine cortical thickness (Fine Ct.Th, μm), cortical porosity 
(Ct.Po, %), pore volume (CtPo.V, mm³), and pore diameter (Ct.Po.Dm, μm). Precision errors in 
our lab ranged from a root-mean squared coefficient of variation (CV%RMS) of 1 to 8% for 
standard evaluation outcomes and from 1% to 11% for advanced cortical evaluation outcomes at 
the radius and tibia in 32 TDC with a mean age of 11.3y (Kawalilak et al., 2017). 
For the purposes of my thesis, I will define bone size as total, cortical, and trabecular area 
and/or volume outcomes as: Tt.Ar, Ct.Ar, Ct.TV, Ct. BV, and Tb.Ar. I will define bone density 
as total, cortical, and trabecular bone and/or tissue mineral density outcomes as: Tt.BMD, 
Ct.BMD, Ct.TMD, and Tb.BMD. I will define cortical micro-architecture as: Apparent Ct.Th, 
Fine Ct.Th, Ct.Po, Ct.Po.V, and Ct.Po.Dm; and trabecular micro-architecture as: BV/TV, Tb.N, 





will herein refer to all these outcomes together as bone size, density, and cortical and trabecular 
micro-architecture (Bunyamin et al., 2019). 
 
4.4 Accelerometer Measurement 
I measured daily minutes of MVPA, VPA, and impact counts ≥3.9g using a triaxial 
accelerometer (model wGT3X-BT, ActiGraph). Participants were instructed to wear the 
accelerometer on their right hip (mid-axillary line) attached using an elastic waist belt for 7 days. 
They were asked to only wear the belt while they were awake, and to remove the belt while they 
were sleeping, or during activities that may damage the accelerometer, such as water activities or 
contact sports. I analyzed accelerometer data based on a systematic review of recommendations 
for accelerometer data processing for children and adolescents (Migueles, Cadenas-Sanchez, 
Ekelund et al., 2017) using software provided by the manufacturer (ActiLife, v6.13.2). They 
recommended using a sampling frequency of 90-100Hz, however data previously collected from 
our sample of TDC was recorded at 30Hz (Kehrig et al., 2019), so I continued to record at 30Hz. 
Migueles et al. (2017) stated that they could not recommend a definition of non-wear time for 
children and adolescents. Based on visual inspection of wear time graphs output by ActiLife 
software, I chose to use the Choi et al. (2011) algorithm (Choi, Liu, Matthews et al., 2011), as 
those graphs adequately matched the wear time reported in each child’s physical activity log. 
This algorithm defines non-wear time as consecutive zero counts for at least 90 minutes, 
allowing for short time intervals with non-zero counts up to 2 minutes (Choi et al., 2011). If no 
counts were recorded 30 minutes before and after the 2-minute time interval, this period of time 
is defined as non-wear (Choi et al., 2011). I was unable to match the wear-time criteria 





(Migueles et al., 2017)). To allow for more participants in my sample, I used a less restrictive 
wear time criteria of at least 3 days with a minimum of 8 hours per day, including 1 day on the 
weekend (Sioen, Michels, Polfliet et al., 2015). I excluded accelerometer recordings that did not 
meet this wear time criteria. Activity counts were stored in 10 second intervals based on previous 
recommendations (Migueles et al., 2017). The thresholds for moderate PA (2296-4011 counts 
per minute, cpm) and VPA (≥4012 cpm) were originally validated using indirect calorimetry 
(estimated VO²) exercise testing on a treadmill in children aged 5 to 8 years (Evenson et al., 
2008), and have since been validated for use in older children and adolescents (Trost et al., 
2011). This is important to note, as the thresholds identifying different intensities of physical 
activity are based on metabolic factors and have not been directly linked to mechanical loading 
of bone. 
To measure daily impacts, I obtained the raw accelerometer data using the feature 
extraction tool from the manufacturer’s software. I used Microsoft Excel Office 365 (version 
1908) to count the total number of impact counts as the number of instances the peak resultant 
acceleration was equal to, or greater than a resultant acceleration of 3.9g on days with a valid 
wear time (Kehrig et al., 2019). The accelerometer was set to sample the peak acceleration value 
every 10 seconds (Kehrig et al., 2019). I calculated daily minutes of MVPA, VPA, and daily 
impact counts as the total minutes of MVPA and VPA, or total number of impact counts divided 








4.5 Forearm and Lower Leg Cross-Sectional Muscle Area 
Another technician and I measured cross-sectional muscle area (mm²) at shaft sites of the 
dominant forearm (65% ulna length) and lower leg (66% tibia length) using peripheral 
quantitative computed tomography (pQCT) (XCT 2000, Stratec Medizintechnik GmbH). Prior to 
imaging the radius and tibia shaft, another technician or I acquired a scout view of the distal 
radius or tibia and placed a reference line at the growth plate. If the scan quality was graded 
poorly (rating 4 or 5), mainly due to excessive patient movement, I excluded the scan from my 
analyses (Duff et al., 2017). We analyzed the image data using the manufacturer’s software 
(version 6.00B). Cross-sectional muscle areas from the forearm and lower leg scans were 
obtained using contour mode 1 with a threshold of 40 mg/cm³ to separate muscle from 
subcutaneous fat. Short-term precision of forearm and lower leg cross-sectional muscle area was 
previously calculated in 31 children. CV%RMS values were reported as 2.8% and 3.6%, 
respectively (Björkman et al., 2017). 
 
4.6 Statistical Methods 
I reported the means and standard deviations of the background characteristics in the DM1 and 
TDC groups and assessed for significant differences in these characteristics between groups 
using independent t-tests. I identified outliers as values outside two standard deviations from the 
group mean using box plots and verified that these values were all correctly entered in the data 





4.6.1 Assumptions Testing 
I tested the assumptions of normality, independence of observations, homogeneity of variance, 
and homogeneity of covariances prior to my analyses. I assessed normality of my variables using 
Q-Q plots and identified any outliers in my data using box plots. I found that daily minutes of 
VPA, daily impacts, Ct.Ar, Ct.TV, Ct.BV, Apparent Ct.Th, Fine Ct.Th, and Tb.Sp.SD at the 
radius, and Ct.TMD, Apparent Ct.Th, and Fine Ct.Th at the tibia were not normally distributed. 
The Durbin Watson statistic was approximately 2 in all of my models, indicating that there was 
an independence of observations. I tested for homogeneity of error variances using Levene’s test. 
I found that apparent Ct.Th and Co.Po violated this assumption in the base model at the radius, 
but no variables violated this assumption in the base model at the tibia. Since several of my 
variables violated the assumption of normality or homogeneity of variances, I applied a natural 
logarithmic transformation to those variables and re-tested these assumptions. All transformed 
variables met the assumptions of normality and homogeneity of variances, so I re-ran analyses 
for my primary and secondary objectives including transformed variables in my models to 
address any potential errors caused by violating these assumptions (Appendix). However, due to 
challenges in the interpretation of logarithmic data, I chose to report my findings without log 
transformations in my results and have provided findings from my models including transformed 
variables in the appendix due to challenges in the interpretation of logarithmic data. Findings 
were comparable between transformed and non-transformed data. (Appendix, Figure 7).  
4.6.2 Using Sex, Maturity, Site-Specific Muscle Area, and BMI z-score as Covariates 
I chose to adjust for sex, years from aPHV (maturity), site-specific muscle area, and BMI z-score 
(body size) in my models since these variables are reported determinants of bone characteristics 





chronological age and maturity between DM1 and TDC groups, I chose to adjust for years from 
aPHV, to account for variation in the somatic maturity, particularly long bone growth, between 
participants (Bunyamin et al., 2019).  
There was no difference in the distribution of boys and girls between DM1 and TDC 
groups, assessed using Chi-square, however all covariates (including sex) were significant 
factors influencing the variance in bone micro-architecture in my models.  
4.6.3 Multivariate Analysis and Pairwise Comparisons of Bone Size, Density, and 
Micro-architecture Between Groups (Primary Objective) 
 For my primary objective, I used two site-specific MANCOVAs to compare bone size, density, 
and cortical and trabecular micro-architecture at the radius and tibia between children with DM1 
and TDC after adjusting for sex, maturity (years from aPHV), site-specific muscle area, and BMI 
z-score. I reported the F-ratios (Pillai’s trace) assessing differences between the groups in the 
radius and tibia models. For post hoc testing, I used pairwise comparisons with Bonferroni 
correction for multiple comparisons. I reported unadjusted group means and standard deviations, 
mean and percent differences in adjusted group means, and 95% confidence intervals of adjusted 
mean differences in bone size, density, and trabecular and cortical micro-architecture between 
children and youth with DM1 and TDC. Significance was set at p<0.05. 
4.6.4 Assessing the Role of Daily MVPA, VPA, and Impacts (Secondary Objective) 
For my secondary objective, I first used site-specific MANCOVAs to assess if daily minutes of 
MVPA, VPA, and daily impacts were factors influencing differences in bone size, density, and 
cortical and trabecular micro-architecture between the groups (children with DM1 vs. TDC). I 
used the radius and tibia MANCOVAs from my primary objective analyses as base models to 





and tibia models. The role of PA was explored in two ways. First, I reported the standardized β-
coefficients of the PA outcomes to assess the independent role of PA in the models of those bone 
outcomes that differed between DM1 and TDC groups; as assessed in my primary objective. I 
also reported standardized β-coefficients of the covariates; sex, maturity (years from aPHV), site-
specific muscle area (forearm or lower leg), and BMI z-score. I chose to report standardized β-
coefficients instead of unstandardized β-coefficients, as standardized β-coefficients are in units 
of standard deviations and allow for a direct comparison of the independent role of PA between 
bone outcomes. Reporting the standardized β-coefficients of my covariates also highlights the 
challenges associated with identifying which covariates should be included in multivariate 
models. I used an explanatory modeling approach (Shmueli, 2010) by reporting the standardized 
β-coefficients (the slope of the regression line) to predict the estimated change in standard 
deviations of the bone outcome per 1 standard deviation change in PA. Second, I reported results 
from pairwise comparisons (Bonferroni) to explore the role of PA on bone outcomes by 
illustrating group differences in bone outcomes between children and youth with DM1 and TDC 
before and after controlling for PA variables that significantly contributed to the model. I 
reported unadjusted group means and standard deviations, mean and percent differences in 
adjusted group means, and 95% confidence intervals of adjusted mean differences in bone size, 
density, and cortical and trabecular micro-architecture between children and youth with DM1 







5.1 Background Characteristics 
Descriptive background characteristics of participants are provided in Table 1. Independent t-
tests showed that our sample of children and youth with DM1 were older (p=0.029) and more 
mature (p=0.035) than our sample of TDC (Table 2). 
Table 2. Background characteristics of children and youth with DM1 and TDC. 
 
5.2 Differences in Bone Size, Density, and Micro-Architecture Between Children with DM1 
and TDC (Primary Objective) 
There was a significant difference in bone size, density, and cortical and trabecular micro-
architecture at the radius (F(18,42)=7.594, p<0.001) and a significant difference in cortical 
  DM1   TDC  
  n Mean SD  n Mean SD p-value 
Number of girls (%) 21 12(57%)   47 22(47%)   
Age (years) 21 12.1 2.1  47 10.9 1.6 0.029 
Age at PHV (years) 21 12.5 0.8  47 12.4 0.7 0.664 
Years from age at PHV (years) 21 -0.4 2.1  47 -1.5 1.5 0.035 
Height (cm) 21 152.2 12.4  47 147.9 12.5 0.200 
Body mass (kg) 21 48.4 16.0  47 42.3 16.2 0.154 
Body mass index 21 20.3 3.8  47 18.8 4.7 0.177 
Body mass index z-score 21 0.53 0.92  47 0.16 1.2 0.158 
Body mass index percentile (%) 21 68.2 26.8  47 54.2 30.7 0.063 
Seated height (cm) 21 80.3 7.3  47 78.0 6.2 0.222 
Leg length (cm) 21 71.9 5.5  47 69.9 6.9 0.213 
Ulna length (mm) 21 240.3 21.9  47 236.3 22.9 0.495 
Tibia length (mm) 21 349.3 28.5  47 356.4 35.6 0.384 
Forearm muscle area (mm²) 21 2538.5 696.8  45 2272.4 663.5 0.151 
Lower leg muscle area (mm²) 21 4668.8 1316.0  45 4409.5 1425.4 0.472 
Daily protein intake (g/day) 21 75.3 40.2  34 61.2 30.8 0.175 
Daily calcium intake (mg/day) 21 923.7 385.9  34 900.3 504.0 0.847 
Daily vitamin D intake (IU/day) 21 139.9 105.7  34 191.4 163.2 0.161 
Daily MVPA (min/day) 21 48.5 21.9  47 51.1 22.3 0.661 
Daily VPA (min/day) 21 15.8 11.0  47 19.2 10.5 0.245 
Daily impacts (# impacts/day) 21 47 52  47 73 59 0.073 
Age at DM1 diagnosis (years) 21 6.8 2.2      
Years since DM1 diagnosis (years) 21 5.3 2.5      





micro-architecture at the tibia (F(18,42)=2.826, p=0.003) between children and youth with DM1 
and TDC. 
5.2.1 Pairwise Comparisons of Percent Differences in Bone Size, Density, and 
Micro-Architecture Between Groups 
At the radius, children with DM1 had a lower total bone area (-13.3%), greater total BMD 
(+12.3%), cortical BMD (+9.3%), cortical TMD (+4.7%), apparent cortical thickness (+21.7%), 
fine cortical thickness (+22.7%); lower cortical porosity (-39.2%), pore volume (-33.6%), pore 
diameter (-11.1%), trabecular area (-18.2%), trabecular number (-6.1%); and greater trabecular 
separation (+7.0%) (Table 3, Figure 4).  
At the tibia, children with DM1 had a lower cortical porosity (-22.5%), pore volume (-
28.4%), and pore diameter (-6.7%) (Table 4, Figure 5). 
Table 3. Descriptive statistics and adjusted† group differences in bone size, density, and micro-
architecture at the radius between children and youth with type 1 diabetes (DM1) and typically 
developing children and youth (TDC). 
  DM1 (n=20)   TDC (n=45)         
  
Mean SD   Mean SD 
*Adj Mean 
Diff 
*95% CI of Adj 
Diff 
*p-value 
              Lower Upper   
Tt.Ar (mm²) 193.3 43.3   208.4 41.0 -28.3 -44.4 -12.1 0.001 
Tt.BMD (mg HA/cm³) 277.9 46.1   246.8 40.7 30.4 8.7 52.0 0.007 
Ct.Ar (mm²) 41.5 12.8   39.7 7.4 -0.4 -4.2 3.5 0.846 
Ct.TV (mm³) 374.7 115.1   358.2 66.3 -3.4 -38.1 31.4 0.846 
Ct.BV (mm³) 336.1 114.3   282.1 54.0 31.8 -0.3 63.9 0.052 
Ct.BMD (mg HA/cm³) 771.0 62.8   690.5 52.4 65.0 37.4 92.6 <0.001 
Ct.TMD (mg HA/cm³) 811.8 55.1   762.6 35.3 35.7 15.0 56.3 0.001 
Apparent Ct.Th (μm) 755.9 208.5   593.0 105.7 131 58.4 202.9 0.001 
Fine Ct.Th (μm) 496.6 120.9   384.6 51.4 89 47.7 129.9 <0.001 
Ct.Po (%) 4.2 1.8   7.6 2.8 -2.9 -4.1 -1.6 <0.001 
Ct.Po.V (mm³) 14.3 8.4   23.0 11.8 -7.6 -12.6 -2.6 0.004 
Ct.Po.Dm (μm) 143 7.1   162 9.9 -18 -21.8 -12.9 <0.001 
Tb.Ar (mm²) 154.8 37.5   177.4 38.8 -32.9 -49.9 -15.9 <0.001 
Tb.BMD (mg HA/cm³) 166.0 28.8   179.1 34.4 -7.8 -23.5 7.9 0.323 
BV/TV (%) 13.8 2.4   14.9 2.9 -0.7 -2.0 0.7 0.322 
Tb.N (1/mm) 2.1 0.2   2.3 0.2 -0.1 -0.3 0.0 0.028 
Tb.Th (μm) 66 8.7   66 9.7 1 -3.5 6.0 0.606 






Figure 4. Percent differences in bone size, density, and micro-architecture at the radius between 
children and youth with type 1 diabetes (DM1) and typically developing children and youth 
(TDC) after adjusting for sex, years from estimated age at peak height velocity, forearm muscle 
area, and BMI z-score. 
 
Abbreviations: Tt.Ar = total bone area, Tt.BMD = total bone mineral density, Ct.Ar = cortical area, Ct.TV = cortical total 
volume, Ct.BV = cortical bone volume, Ct.BMD = cortical bone mineral density, Ct.TMD = cortical tissue mineral 
density, Ct.Th = cortical thickness, Ct.Po = cortical porosity, Ct.Po.V = cortical pore volume, Ct.Po.Dm = cortical pore 
diameter, Tb.Ar = trabecular area, Tb.BMD = trabecular bone mineral density, BV/TV = trabecular bone volume 
fraction, Tb.N = trabecular number, Tb.Th = trabecular thickness, Tb.Sp = trabecular separation, Tb.Sp.SD = trabecular 
heterogeneity.




















Percent difference in DM1 compared to TDC (%)
Error bars denote 95% confidence 
intervals of the difference
Tb.Sp.SD (μm) 163 26.5   147 32.3 10 -6.4 25.5 0.237 
Abbreviations: Tt.Ar = total bone area, Tt.BMD = total bone mineral density, Ct.Ar = cortical area, Ct.TV = 
cortical total volume, Ct.BV = cortical bone volume, Ct.BMD = cortical bone mineral density, Ct.TMD = cortical 
tissue mineral density, Ct.Th = cortical thickness, Ct.Po = cortical porosity, Ct.Po.V = cortical pore volume, 
Ct.Po.Dm = cortical pore diameter, Tb.Ar = trabecular area, Tb.BMD = trabecular bone mineral density, BV/TV 
= trabecular bone volume fraction, Tb.N = trabecular number, Tb.Th = trabecular thickness, Tb.Sp = trabecular 
separation, Tb.Sp.SD = trabecular heterogeneity. *Bonferroni adjustment for multiple comparisons. †Covariates 
were evaluated as sex (girls=1, boys=2), years from age at PHV = -1.17y, forearm muscle area = 2327.4 mm², 





Table 4. Descriptive statistics and adjusted† group differences in bone size, density, and micro-
architecture at the tibia between children and youth with type 1 diabetes (DM1) and typically 











  DM1 (n=20)   TDC (n=45)         
  
Mean SD   Mean SD 
*Adj Mean 
Diff 
*95% CI of Adj 
Diff 
*p-value 
              Lower Upper   
Tt.Ar (mm²) 682.3 107.0   673.4 115.3 -40.6 -89.8 8.7 0.104 
Tt.BMD (mg HA/cm³) 239.3 32.5   236.4 31.6 -0.8 -18.4 16.9 0.930 
Ct.Ar (mm²) 80.3 20.2   78.9 16.5 -7.1 -15.2 1.1 0.088 
Ct.TV (mm³) 723.9 182.3   711.9 149.2 -63.8 -137.5 9.8 0.088 
Ct.BV (mm³) 629.9 176.7   585.8 128.7 -30.2 -96.1 35.8 0.364 
Ct.BMD (mg HA/cm³) 757.3 73.6   719.1 42.0 14.4 -15.1 43.9 0.333 
Ct.TMD (mg HA/cm³) 813.5 64.2   788.8 33.1 0.7 -22.3 23.7 0.953 
Apparent Ct.Th (μm) 751.0 184.5   683.1 0.2 -3 -91.0 85.9 0.954 
Fine Ct.Th (μm) 435.8 93.1   389.5 0.0 20 -16.4 56.5 0.276 
Ct.Po (%) 6.1 2.3   8.0 0.0 -1.8 -3.2 -0.3 0.018 
Ct.Po.V (mm³) 40.4 17.8   52.0 23.8 -15.1 -27.6 -2.6 0.018 
Ct.Po.Dm (μm) 152 7.9   163 0.0 -11 -15.8 -5.4 <0.001 
Tb.Ar (mm²) 607.9 96.4   601.5 111.3 -41.1 -90.5 8.2 0.101 
Tb.BMD (mg HA/cm³) 180.4 19.0   187.5 24.4 -5.3 -18.4 7.8 0.422 
BV/TV (%) 15.0 1.6   15.6 0.0 -0.5 -1.5 0.6 0.414 
Tb.N (1/mm) 2.1 0.2   2.1 0.3 0.0 -0.1 0.1 0.964 
Tb.Th (μm) 74 9.5   76 0.0 -3 -9.0 3.3 0.353 
Tb.Sp (μm) 416 42.7   412 0.1 -2 -33.1 29.2 0.901 
Tb.Sp.SD (μm) 174 30.8   170 0.0 -2 -21.5 17.2 0.822 
Abbreviations: Tt.Ar = total bone area, Tt.BMD = total bone mineral density, Ct.Ar = cortical area, Ct.TV = cortical 
total volume, Ct.BV = cortical bone volume, Ct.BMD = cortical bone mineral density, Ct.TMD = cortical tissue 
mineral density, Ct.Th = cortical thickness, Ct.Po = cortical porosity, Ct.Po.V = cortical pore volume, Ct.Po.Dm = 
cortical pore diameter, Tb.Ar = trabecular area, Tb.BMD = trabecular bone mineral density, BV/TV = trabecular 
bone volume fraction, Tb.N = trabecular number, Tb.Th = trabecular thickness, Tb.Sp = trabecular separation, 
Tb.Sp.SD = trabecular heterogeneity. *Bonferroni adjustment for multiple comparisons. †Covariates were 
evaluated as sex (girls=1, boys=2), years from age at PHV = -1.1y, lower leg muscle area = 4519.9 mm², and 





Figure 5. Percent differences in bone size, density, and micro-architecture at the tibia between 
children and youth with type 1 diabetes (DM1) and typically developing children and youth 
(TDC) after adjusting for sex, years from estimated age at peak height velocity, lower leg muscle 
area, and BMI z-score. 
 
 
5.3 Role of Daily MVPA, VPA, and Impacts on Bone Size, Density and Micro-Architecture 
in Children with DM1 and TDC (Secondary Objective) 
Daily minutes of VPA independently predicted the variance in cortical pore diameter at the 
radius (Std. β=-0.18, p=0.033), but did not independently predict the variance in total bone area, 
Abbreviations: Tt.Ar = total bone area, Tt.BMD = total bone mineral density, Ct.Ar = cortical area, Ct.TV = cortical total 
volume, Ct.BV = cortical bone volume, Ct.BMD = cortical bone mineral density, Ct.TMD = cortical tissue mineral 
density, Ct.Th = cortical thickness, Ct.Po = cortical porosity, Ct.Po.V = cortical pore volume, Ct.Po.Dm = cortical pore 
diameter, Tb.Ar = trabecular area, Tb.BMD = trabecular bone mineral density, BV/TV = trabecular bone volume 
fraction, Tb.N = trabecular number, Tb.Th = trabecular thickness, Tb.Sp = trabecular separation, Tb.Sp.SD = trabecular 
heterogeneity.
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Error bars denote 95% confidence 





total or cortical BMD, cortical TMD, apparent or fine cortical thickness, cortical porosity, pore 
volume, trabecular area, number, or separation (Table 5). Daily minutes of MVPA and daily 
impacts did not contribute to the overall variance in bone size, density, and micro-architecture at 
the radius (p=0.650, p=0.131) or at the tibia (p=0.417, p=0.791), respectively. 
Table 5. Standardized β-coefficients of base model covariates and daily minutes of vigorous 
physical activity (VPA) for bone size, density, and micro-architecture at the radius in a pooled 
sample of children and youth with type 1 diabetes (DM1) and typically developing children and 
youth (TDC). 
    Std. β p-value 
Tt.Ar Sex 0.26 0.040 
  Maturity (years from aPHV) 0.59 <0.001 
  Forearm muscle area 0.29 0.073 
  Body mass index z-score 0.01 0.952 
  Daily VPA 0.16 0.076 
  Group (DM1 and TDC) -0.30 0.001 
Tt.BMD Sex -0.01 0.932 
  Maturity (years from aPHV) -0.26 0.189 
  Forearm muscle area 0.56 0.010 
  Body mass index z-score -0.02 0.881 
  Daily VPA -0.06 0.583 
  Group (DM1 and TDC) 0.31 0.009 
Ct.BMD Sex 0.18 0.180 
  Maturity (years from aPHV) 0.44 0.010 
  Forearm muscle area -0.37 0.042 
  Body mass index z-score 0.51 <0.001 
  Daily VPA -0.04 0.698 
  Group (DM1 and TDC) 0.45 <0.001 
Ct.TMD Sex 0.17 0.242 
  Maturity (years from aPHV) 0.48 0.007 
  Forearm muscle area -0.20 0.274 
  Body mass index z-score 0.40 0.004 
  Daily VPA -0.13 0.199 
  Group (DM1 and TDC) 0.33 0.002 
Apparent Ct.Th Sex 0.14 0.327 
  Maturity (years from aPHV) 0.28 0.119 
  Forearm muscle area 0.21 0.266 
  Body mass index z-score 0.05 0.694 
  Daily VPA -0.18 0.083 
  Group (DM1 and TDC) 0.36 0.001 
Fine Ct.Th Sex 0.15 0.290 
  Maturity (years from aPHV) 0.50 0.006 
  Forearm muscle area -0.28 0.139 
  Body mass index z-score 0.28 0.036 
  Daily VPA -0.17 0.094 
  Group (DM1 and TDC) 0.42 <0.001 






Pairwise comparisons revealed that group differences in radius bone size, density, 
cortical and trabecular micro-architecture between children with DM1 and TDC remained after 
adjusting for daily minutes of VPA, excluding trabecular separation (p=0.054) (Table 6). After 
adjusting for VPA, children with DM1 had a lower total bone area (-12.6%); greater total BMD 
(+12.0%), cortical BMD (+9.3%), cortical TMD (+4.5%), apparent cortical thickness (+20.5%), 
  Maturity (years from aPHV) -0.44 0.015 
  Forearm muscle area 0.69 <0.001 
  Body mass index z-score -0.54 <0.001 
  Daily VPA -0.04 0.730 
  Group (DM1 and TDC) -0.45 <0.001 
Ct.Po.V Sex -0.07 0.603 
  Maturity (years from aPHV) -0.46 0.012 
  Forearm muscle area 0.95 <0.001 
  Body mass index z-score -0.49 0.001 
  Daily VPA -0.06 0.551 
  Group (DM1 and TDC) -0.31 0.003 
Ct.Po.Dm Sex -0.03 0.808 
  Maturity (years from aPHV) -0.12 0.377 
  Forearm muscle area 0.37 0.014 
  Body mass index z-score -0.55 <0.001 
  Daily VPA -0.18 0.033 
  Group (DM1 and TDC) -0.66 <0.001 
Tb.Ar Sex 0.21 0.122 
  Maturity (years from aPHV) 0.51 0.004 
  Forearm muscle area 0.26 0.149 
  Body mass index z-score -0.03 0.794 
  Daily VPA 0.19 0.060 
  Group (DM1 and TDC) -0.37 <0.001 
Tb.N Sex -0.36 0.034 
  Maturity (years from aPHV) -0.68 0.002 
  Forearm muscle area 0.65 0.004 
  Body mass index z-score -0.12 0.437 
  Daily VPA 0.05 0.653 
  Group (DM1 and TDC) -0.26 0.033 
Tb.Sp Sex 0.33 0.049 
  Maturity (years from aPHV) 0.71 0.001 
  Forearm muscle area -0.71 0.002 
  Body mass index z-score 0.16 0.307 
  Daily VPA -0.08 0.492 
  Group (DM1 and TDC) 0.23 0.054 
Abbreviations: Tt.Ar = total bone area, Tt.BMD = total bone mineral density, Ct.Ar = cortical area, Ct.TV = 
cortical total volume, Ct.BV = cortical bone volume, Ct.BMD = cortical bone mineral density, Ct.TMD = cortical 
tissue mineral density, Ct.Th = cortical thickness, Ct.Po = cortical porosity, Ct.Po.V = cortical pore volume, 
Ct.Po.Dm = cortical pore diameter, Tb.Ar = trabecular area, Tb.BMD = trabecular bone mineral density, BV/TV 
= trabecular bone volume fraction, Tb.N = trabecular number, Tb.Th = trabecular thickness, Tb.Sp = trabecular 





fine cortical thickness (+21.6%); and a lower cortical porosity (-39.2%), pore volume (-34.2%), 
pore diameter (-11.1%), trabecular area (-17.4%), and number (-6.0%) at the radius (Table 6, 
Figure 6). 
Table 6. Descriptive statistics of bone size, density, and micro-architecture at the radius between 
children and youth with type 1 diabetes (DM1) and typically developing children and youth 
(TDC). Adjusting† for covariates in base model, as well as daily minutes of vigorous physical 
activity (VPA). 
  DM1 (n=20)   TDC (n=45)         
  
Mean SD   Mean SD 
*Adj Mean 
Diff 
*95% CI of Adj 
Diff 
*p-value 
              Lower Upper   
Tt.Ar (mm²) 193.3 43.3   208.4 41.0 -26.8 -42.7 -10.9 0.001 
Tt.BMD (mg HA/cm³) 277.9 46.1   246.8 40.7 29.8 7.9 51.6 0.009 
Ct.Ar (mm²) 41.5 12.8   39.7 7.4 -0.6 -4.5 3.2 0.739 
Ct.TV (mm³) 374.7 115.1   358.2 66.3 -5.8 -40.5 28.9 0.739 
Ct.BV (mm³) 336.1 114.3   282.1 54.0 29.6 -2.5 61.6 0.070 
Ct.BMD (mg HA/cm³) 771.0 62.8   690.5 52.4 64.4  36.5 92.4 <0.001 
Ct.TMD (mg HA/cm³) 811.8 55.1   762.6 35.3 34.3 13.7 54.9 0.002 
Apparent Ct.Th (μm) 755.9 208.5   593.0 105.7 124 0.1 0.2 0.001 
Fine Ct.Th (μm) 496.6 120.9   384.6 51.4 85 0.0 0.1 <0.001 
Ct.Po (%) 4.2 1.8   7.6 2.8 -2.9 0.0 0.0 <0.001 
Ct.Po.V (mm³) 14.3 8.4   23.0 11.8 -7.8 -12.8 -2.7 0.003 
Ct.Po.Dm (μm) 143 7.1   162 9.9 -18 0.0 0.0 <0.001 
Tb.Ar (mm²) 154.8 37.5   177.4 38.8 -31.3 -48.0 -14.5 <0.001 
Tb.BMD (mg HA/cm³) 166.0 28.8   179.1 34.4 -7.3 -23.2 8.6 0.360 
BV/TV (%) 13.8 2.4   14.9 2.9 -0.6 0.0 0.0 0.359 
Tb.N (1/mm) 2.1 0.2   2.3 0.2 -0.1 -0.3 0.0 0.033 
Tb.Th (μm) 66 8.7   66 9.7 1 0.0 0.0 0.573 
Tb.Sp (μm) 416 51.4   381 51.0 26 0.0 0.1 0.054 
Tb.Sp.SD (μm) 163 26.5   147 32.3 9 0.0 0.0 0.260 
Abbreviations: Tt.Ar = total bone area, Tt.BMD = total bone mineral density, Ct.Ar = cortical area, Ct.TV = 
cortical total volume, Ct.BV = cortical bone volume, Ct.BMD = cortical bone mineral density, Ct.TMD = 
cortical tissue mineral density, Ct.Th = cortical thickness, Ct.Po = cortical porosity, Ct.Po.V = cortical pore 
volume, Ct.Po.Dm = cortical pore diameter, Tb.Ar = trabecular area, Tb.BMD = trabecular bone mineral 
density, BV/TV = trabecular bone volume fraction, Tb.N = trabecular number, Tb.Th = trabecular thickness, 
Tb.Sp = trabecular separation, Tb.Sp.SD = trabecular heterogeneity. *Bonferroni adjustment for multiple 
comparisons. †Covariates were evaluated as sex (girls=1, boys=2), years from age at PHV = -1.17, forearm 











Figure 6. Percent differences in bone size, density, and micro-architecture at the radius between 
children and youth with type 1 diabetes (DM1) and typically developing children and youth 
(TDC) in the base model without adjusting for vigorous physical activity (VPA) and after 
adjusting for VPA. 
  
Abbreviations: Tt.Ar = total bone area, Tt.BMD = total bone mineral density, Ct.Ar = cortical area, Ct.TV = cortical total 
volume, Ct.BV = cortical bone volume, Ct.BMD = cortical bone mineral density, Ct.TMD = cortical tissue mineral 
density, Ct.Th = cortical thickness, Ct.Po = cortical porosity, Ct.Po.V = cortical pore volume, Ct.Po.Dm = cortical pore 
diameter, Tb.Ar = trabecular area, Tb.BMD = trabecular bone mineral density, BV/TV = trabecular bone volume 
fraction, Tb.N = trabecular number, Tb.Th = trabecular thickness, Tb.Sp = trabecular separation, Tb.Sp.SD = trabecular 
heterogeneity.
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6.1 Differences in Bone Size, Density, and Micro-Architecture Between Children with DM1 
and TDC 
6.1.1 Total and Cortical Bone Size and Density, and Cortical Micro-Architecture 
The results of my primary objective suggest that children with DM1 had 11-39% lower total 
area, cortical porosity, pore volume, and pore diameter, and 5-23% greater total BMD, cortical 
BMD, cortical TMD, and apparent and fine cortical thicknesses compared to the TDC group at 
the radius, and 7-28% lower cortical porosity, pore volume, and pore diameter at the tibia after 
adjusting for sex, maturity, site-specific muscle area (forearm or lower leg), and BMI z-score. 
Observed smaller bone size (Bechtold et al., 2007; Roggen et al., 2013; Saha et al., 2009), and 
greater cortical densities (Maratova et al., 2018) in children with DM1 agree with most of the 
previous literature whereas my observations of a thicker and less porous cortical micro-
architecture were not reported in previous literature (Table 1). At its surface, these findings do 
not appear to fit into the narrative of higher fracture rates in children with DM1. Based on 
mechanical test data, a denser and thicker cortical bone structure is thought to be more 
structurally favourable (Muller et al., 2008). This study found that cortical thickness was a better 
predictor of bone failure load than total BMD at the radius shaft, where cortical thickness 
predicted 72% of the variance in failure load compared to 42% of the variance predicted by total 
BMD (Muller et al., 2008).  
However, it is still possible that children with DM1 may present with a structurally 
beneficial cortical bone micro-architecture may still be subject to a greater fracture risk than 
TDC, as total and trabecular bone size, density, and trabecular micro-architecture may play a 





van Rietbergen et al., 2011; Kontulainen, Johnston, Liu et al., 2008). Previous mechanical test 
data found that compressive bone strength, estimated as a product of total bone area and total 
density squared, predicted up to 85% of the variance in compressive failure load at the distal 
tibia (Kontulainen et al., 2008). Findings from a prospective study of 176 boys found that boys 
with fractures had a lower trabecular BMD and trabecular number, but not cortical BMD or 
thickness, compared to boys without fractures (Chevalley et al., 2011). It is important to make 
the distinction that I am reporting cortical bone characteristics at the distal region of the radius 
and tibia, whereas cortical bone findings derived from pQCT studies measured cortical bone 
properties at shaft sites of the radius or tibia.  
From a cross-sectional point of view, several studies reported a lower cortical area, 
content and/or thickness (Maratova et al., 2018; Moyer-Mileur et al., 2004; Saha et al., 2009), or 
density (Bechtold et al., 2007; Weber, Gordon, Kelley et al., 2019) in children with DM1. These 
findings seem contradictory to those presented in my thesis. However, other studies either 
reported no significant differences in cortical density (Heap et al., 2004; Lettgen et al., 1995; 
Saha et al., 2009), and cortical area (Heap et al., 2004), or reported a greater cortical density in 
children with DM1, similar to my own findings (Maratova et al., 2018; Moyer-Mileur et al., 
2004). Interestingly, Moyer-Mileur et al. (2004) reported lower gains in cortical bone area, 
content, density, and torsional bone strength (compared to predicted change data of TDC) in 
children with DM1 despite reporting a greater cortical density at baseline (Moyer-Mileur et al., 
2004). Findings from Moyer-Mileur et al. (2004) may be explained by previous evidence from 
an experimental study in osteoblasts. This study found that higher glucose concentrations speed 





Hernandez, Arzate, Gil-Chavarria et al., 2012). This may help to explain why children with DM1 
in my study had a greater total and cortical BMD, cortical TMD, and cortical thicknesses.  
As there is limited evidence observing differences in total and cortical bone properties 
between children and youth with DM1 and TDC, discrepancies of my thesis findings compared 
to previous literature may be explained by differences in ages between participants, the use of 
pQCT instead of HR-pQCT, and measuring cortical outcomes at the tibia shaft, instead of at the 
radius. First, three of the studies that reported lower cortical densities or thicknesses studied 
adolescents with a mean age of 14-16y (Maratova et al., 2018; Moyer-Mileur et al., 2004; Weber 
et al., 2019), compared to the younger mean age my participants (11.3y). Three studies that 
disagreed with my findings and reported lower densities or cortical thicknesses measured these 
outcomes at the tibia shaft using pQCT (Maratova et al., 2018; Moyer-Mileur et al., 2004; Weber 
et al., 2019), instead of at the distal radius using HR-pQCT. It is more common to only measure 
cortical bone properties at shaft sites using pQCT, instead of at the distal region using HR-
pQCT. As bone adaptation is site-specific, there are also site-specific variations in bone 
properties at the weight-bearing tibia compared to the non-weight-bearing radius in children (D. 
Liu et al., 2010). Due to a limited number of studies assessing bone in children and youth with 
DM1, I am not able to directly compare my thesis findings to previous studies without running 
into issues of external validity. 
6.1.2 Trabecular Bone Size, Density, and Trabecular Micro-Architecture 
The results of my primary objective suggest that children with DM1 had 18% lower trabecular 
area, 6% lower trabecular number, and 7% greater trabecular separation compared to the TDC 
group at the radius, but no differences at the tibia after adjusting for sex, maturity, site-specific 





the previous study reporting an 8% lower trabecular number and 13% greater trabecular 
separation, as well as a 7% lower trabecular bone volume fraction in children with DM1 using 
MRI at the proximal end of the tibia (Chen et al., 2019).  
Other studies did not assess trabecular bone micro-architecture, but their findings follow 
a similar pattern of DM1-related deficits in trabecular bone size and/or density (Heap et al., 
2004; Lettgen et al., 1995; Maratova et al., 2018; Moyer-Mileur et al., 2004; Saha et al., 2009; 
Weber et al., 2019). In contrast to these previous studies, Bechtold et al. (2007) reported a higher 
trabecular density in children with DM1 (mean age=9.9y). However, a major limitation of this 
study was that these differences were compared to normative data, z-scores, and predicted 
changes of a typically-developing reference population. They interpreted their findings based on 
normative data, and also stated that DM1-related differences in bone characteristics had 
normalized after 5.5 years (Bechtold et al., 2007). Differences in my thesis findings may be due 
to the younger age at which baseline measurements were recorded (9.9y mean age) in this study. 
Most of the children in Bechtold et al. (2007) were pre-pubertal (27 of 41 total), and these 
children had a lower mean length of DM1 diagnosis was (4.3y at baseline) compared to my 
sample (5.3y). Site-specific differences in weight-bearing (tibia) and non-weight-bearing (radius) 
sites (D. Liu et al., 2010) may also explain why DM1-related deficits in total bone size, density, 
trabecular area, and trabecular micro-architecture were only present at the radius. I suggest that 
the weight-bearing activity at the tibia may have provided enough of a mechanical loading 
stimulus, to be protective against DM1-related metabolic differences, mostly as a result of 
hyperglycaemia, and potentially underlying the deficits observed at the non-weight-bearing 





suggest a weaker trabecular bone morphology at the radius in children with DM1, which may 
underpin higher fracture rates, particularly at the wrist.   
 
6.2 Role of PA on Bone Size, Density, and Micro-Architecture 
The results of my secondary objective show that daily minutes of VPA independently predicted 
cortical pore diameter at the radius (Std. β=-0.18, p=0.033). This finding suggests a negative 
relationship between daily VPA and cortical pore diameter, however due to the low sample size 
of children with DM1 (n=21), I did not have power to test if there was an interaction between 
group and PA. I assessed a mixed-cohort of children with DM1 and TDC, so it is still unclear if 
this relationship is different between groups. Pairwise comparisons revealed that after controlling 
for daily minutes of VPA, there were still significant differences in bone outcomes between 
DM1 and TDC groups. However, trabecular separation was no longer significantly different 
between groups and there was only a very slight change in the magnitude of percent differences 
between groups (ranged from -0.7% to 1.2%) after adjusting for daily VPA. Trabecular 
separation not remaining as significantly different between groups after controlling for VPA is 
likely a result of a loss in statistical power after controlling for an additional covariate. This 
increased my likelihood of a type II error as the p-value for trabecular separation changed from 
p=0.044 to 0.054 (Table 3, Table 6). Further, after applying logarithmic transformations to 
variables that were not normally distributed; including daily minutes of VPA, daily minutes of 
VPA also independently predicted the variance in cortical TMD and fine cortical thickness 





Previous PA studies report a beneficial relationship between MVPA, VPA and/or impacts 
and bone outcomes at the weight-bearing tibia (Gabel et al., 2017b; Gabel et al., 2017c; Janz et 
al., 2014; Kehrig et al., 2019). Longitudinal evidence supports that boys and girls who had higher 
levels of PA throughout childhood and into late adolescence had better bone geometry than their 
peers with lower levels of PA (Janz et al., 2014). This may be a concern for children with DM1, 
as previous study findings reported lower levels of MVPA in children with DM1 (Valerio et al., 
2007). In my thesis data, however, there were no differences in daily minutes of MVPA, VPA, or 
number of impacts between groups. No previous studies have reported a relationship between PA 
and cortical pore diameter in TDC, however MVPA was identified as a positive independent 
predictor of total bone area and cortical porosity at the tibia, but not at the radius in TDC (Gabel 
et al., 2017c). It is important to also note that Gabel et al. (2017c) studied healthy adolescents, 
did not adjust models for site-specific muscle area, and the average entry age was about 15 years 
(Gabel et al., 2017c) which challenges comparison to my data. Due to limitations in statistical 
power to assess group-VPA interaction effects, and a limited number of studies exploring the 
relationship between PA and cortical micro-architecture, my thesis findings should be considered 
preliminary and future studies including larger sample of children and youth with DM1 are 
warranted. 
 
6.3 Role of Maturity on Bone Size, Density, and Micro-Architecture 
As long bones develop, it is important to consider that differences in maturity and growth-related 
changes in bone size, density, and micro-architecture may influence group differences in these 
bone outcomes in pediatric populations (Bunyamin et al., 2019; Gabel et al., 2017a). Evidence of 





limited. However, our group previously reported 1-year changes at the distal radius and tibia 
bone in children with a mean age of 10.4y at baseline to 11.5y at follow-up (Bunyamin et al., 
2019). At both sites, total bone area and density, cortical density and thickness, trabecular 
density and thickness increased while cortical porosity, and pore diameter declined (Bunyamin et 
al., 2019). These findings suggest that larger bone sizes, with a greater density and lower 
porosity, could be anticipated in a more mature group of children. This is important to consider, 
as the DM1 group was approximately 1-year older and more mature than the TDC group, and 
several of the group differences in bone outcomes I observed in children with DM1 may be 
explained by their greater maturity; despite of my attempted to control for the influence of 
maturity by adjusting for maturity in the models. 
 
6.4 Low Bone Turnover in Children with DM1 
Differences in bone size, density, and micro-architecture between groups may also be explained 
by the lower levels of bone turnover in individuals with DM1 (Hygum et al., 2017; Napoli et al., 
2017). Changes at distal region of long bones during growth (including bone modeling and 
remodeling) are likely due to consolidation of the cortex (Bunyamin et al., 2019). This 
consolidation may be due to fusion of smaller trabeculae into the cortical bone (Bunyamin et al., 
2019). It is possible that these structural differences observed in children with DM1, such as a 
lower total bone area, in the presence of a thicker cortex and lower levels of cortical porosity 
observed may reflect lower bone turnover. Previous findings also highlight lower levels of bone 
formation markers reported in children with DM1 (Chen et al., 2019; Napoli et al., 2017). Chen 
et al. (2019) reported a lower bone-specific alkaline phosphatase (marker of bone formation) in 





2019). I do not suspect that lower levels of cortical porosity in children with DM1 will carry into 
adulthood, as previous evidence has shown that cortical porosity and pore volume were greater 
in adult men and women with diabetes, whereas they found no significant differences in total 
bone size and cortical thickness (Paccou, Ward, Jameson et al., 2016). These new observations 
of lower levels of cortical porosity in children with DM1 offer a stark contrast to the greater 
levels of cortical porosity in adults with DM1 which may serve as the basis for investigating 
longitudinal changes in cortical porosity from childhood to adulthood in individuals with DM1. 
Based on previous associations of HR-pQCT outcomes in boys and girls with low-energy 
fractures, greater total BMD, cortical BMD and cortical thickness may be considered beneficial 
for resisting fractures (Farr, Amin, Melton et al., 2014; Määttä et al., 2015; Macdonald et al., 
2018). Whereas, a lower trabecular thickness (Määttä et al., 2015), lower trabecular number, or 
greater trabecular separation (Farr et al., 2014) may be considered detrimental. Physiological 
factors inducing oxidative stress and inflammation, low levels of IGF-1 or insulin may better 
explain differences in bone micro-architecture in children and youth with DM1. 
 
6.5 Role of BMI and Nutrition on Bone Size, Density, and Micro-Architecture 
BMI and nutrition are important factors influencing bone outcomes in children and youth 
(Määttä et al., 2015; Sioen et al., 2015). It has been recommended to adjust bone comparisons for 
the BMI z-score in children with DM1, as they are reported to have BMIs above the 50th centile 
for their age (Johnson, Cooper, Jones et al., 2013). BMI is a good population-based measurement 
of body size, and positively associated with trabecular density and trabecular number, and 





Findings from my thesis did not agree with previous findings that children with DM1 have a 
higher BMI z-score than TDC (DM1 group, BMI z-score=0.53; compared to TDC group, BMI z-
score=0.16, p=0.158). This may be due to a possible selection bias in our small sample of 
children with DM1.  
Nutrition is also an important factor for achieving optimal bone growth and development. 
Previous literature states that skeletal growth and development is impaired at very low protein 
intakes (Ginty, 2003), and dairy consumption are positively associated with DXA measurements 
of bone mineral content and areal BMD (Sioen et al., 2015). A previous study investigating the 
modulating role of nutritional factors on QUS-measured bone status in children with DM1 found 
no differences in calcium intake and serum levels of vitamin D between children with DM1 and 
sex- and age-matched controls (Galluzzi, Stagi, Salti et al., 2005). To address the potential 
disparity in nutritional intakes between children and youth with DM1 and TDC, child 
participants and their parents were instructed to complete a food-frequency questionnaire as 
previously stated in the methods. However, there were no significant differences in daily intake 
of protein, calcium, or vitamin D between children with DM1 and TDC.  
 
6.6 Strengths and Limitations 
There are definite strengths and limitations of my thesis that are important to discuss. The main 
strengths of my thesis include the tools I used to measure bone size, density, and micro-
architecture and record physical activity. First, HR-pQCT is an excellent tool for assessing 
populations at a higher risk of obtaining a bone fracture, as previous studies have found that 





with fracture risk in older adults independent of aBMD (Samelson et al., 2019), which is the 
current clinical method used to predict fracture risk. The short-term precision and reliability of 
HR-pQCT for use in child populations has also been assessed (Bunyamin et al., 2019; Kawalilak 
et al., 2017). Second, the accelerometers used in this study have been validated for objectively-
measuring different intensities of physical activity in children and youth (Evenson et al., 2008; 
Trost et al., 2011) and have been previously used to assess impact counts in children (Kehrig et 
al., 2019). Both of these tools offer substantial improvements to tools used in other studies, 
namely DXA and self-reported physical activity questionnaires (Maggio et al., 2012).  
The limitations of my findings including the cross-sectional design, a small sample size 
of children with DM1, a difference in maturity between groups, and the potential for a selection 
bias in our sample of children and youth with DM1. First, I used a cross-sectional design to 
address my objectives. As a result, I was unable to observe changes in bone size, density, and 
micro-architecture during growth, as that may have yielded important evidence. I was also 
unable to causatively link bone micro-architecture and PA using a cross-sectional design. 
Instead, I was only able to identify VPA as an independent factor influencing cortical pore 
diameter in a pooled sample of children with DM1 and TDC. Second, I had a small sample size 
of children with DM1 (n=21). Therefore, I was unable to assess group-sex or group-PA 
interactions, run sex-specific analyses, or control for other variables such as length of DM1 
diagnosis, nutritional or hormone factors. Third, the DM1 group was more mature than the TDC 
group. I adjusted for the difference in maturity in my analyses, however this may have been 
better addressed through case-control matching in a larger sample. This would have eliminated 
the difference in maturity between groups. Fourth, there is the potential for a selection bias in our 





diabetes camps, and diabetes family days which may cater to children from families of a higher 
socioeconomic status. Since socioeconomic status was not measured, there is the potential that 
these recruitment venues did not allow for the inclusion of a representative sample of children 
from families with a low socioeconomic status, which has been shown to be associated with 
poorer glycemic control in children with DM1 (Hassan, Loar, Anderson et al., 2006). 
 
6.7 Directions for Future Research 
Since we are assessing children, we can gain valuable insight into how DM1 may adversely 
affect bone development using evidence from change data. My thesis offers a good basis of 
support that may be used to guide researchers assessing longitudinal changes in total, cortical, 
and trabecular area, density, and micro-architecture development in children with DM1 followed 
into adulthood and an RCT assessing the effectiveness of a vigorous intensity PA program on 
children with DM1. Future researchers may also want to consider the roles of hyperglycaemia, 
oxidative stress, AGEs, marrow composition, inflammatory factors and adipokines, and the 
lower activation frequency of bone remodelling units on bone in people with DM1 (Chen et al., 
2019; Napoli et al., 2017). For the RCT assessing the efficacy of a VPA on bone size, density, 
and micro-architecture, researchers may choose to recruit children and youth with DM1 and 
TDC into their study and randomize them into a vigorous PA exercise group or light PA group 
(control group); for a total of 4 groups. It would be important for researchers to track the duration 
and intensity of physical activity using an objective tool, such as an accelerometer during the 
intervention sessions. Baseline and follow-up measurements could include HR-pQCT assessment 
of bone density and micro-architecture at the radius and tibia, pQCT muscle area, and 





thesis. Additionally, researchers may want to consider tracking potential mediators of bone 
micro-architecture in children with DM1 such as: daily blood glucose levels (hyperglycaemia), 
markers of oxidative stress, AGEs, inflammation, marrow adiposity, IGF-1, and insulin. This 
study would help us to determine how bone micro-architecture develops in children with DM1, if 
VPA is effective at improving bone micro-architecture, and if these various physiological factors 
underpin the high fracture rates in children with DM1. 
 
7 CONCLUSIONS 
7.1 Conclusions of Primary Objective 
This thesis is the first to provide evidence of the differences, particularly in cortical bone micro-
architecture between children and youth with DM1 and TDC. Children and youth with DM1 had 
observed deficits total bone area, alongside a greater total BMD, cortical BMD, and cortical 
thickness, and a lower cortical porosity, pore volume, pore diameter, trabecular area, trabecular 
number, and a greater trabecular separation at the radius. Lower cortical porosity, pore volume, 
and pore diameter was also observed the tibia. 
 
7.2 Conclusions of Secondary Objective 
My thesis also provides preliminary evidence that daily minutes of VPA may play an 
independent role predicting the variance in cortical bone micro-architecture in a mixed-cohort of 
children and youth with DM1 and TDC. However, it is likely that VPA only plays a minor role 





differences in total, cortical, and trabecular area, density, and micro-architecture outcomes 
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To address potential errors in my results that may be due to variables that failed to meet the 
assumptions of normality and homogeneity of variances, I opted to re-run my analyses after 
applying a natural log transformation to the variables that did not meet these assumptions. 
Variables in my models that failed to meet the assumption of normality include: daily minutes of 
VPA, daily impacts, Tb.Sp.SD, Ct.Ar, Ct.TV, Ct.BV, apparent Ct.Th, Fine Ct.Th at the radius, 
and Ct.TMD, apparent Ct.Th, and fine Ct.Th at the tibia. Variables that failed to meet the 
assumption of homogeneity of variance include, apparent Ct.Th and Co.Po at the radius. After 
applying natural log transformations to the variables above, I re-tested assumptions and re-ran 
analyses for my primary and secondary objectives. All transformed variables now met the 
assumptions of normality and homogeneity of variances.  
For my primary objective, I found significant differences in bone size, density, and 
cortical and trabecular micro-architecture radius (F=7.61, p<0.001) and significant differences in 
cortical micro-architecture at the tibia (F=3.01, p=0.002) between children and youth with DM1 
and TDC. At the radius, children with DM1 had a lower total bone area, greater total BMD, 
cortical BMD, cortical TMD, apparent cortical thickness, fine cortical thickness; lower cortical 
porosity, pore volume, pore diameter, trabecular area, trabecular number; and greater trabecular 
separation (Table 7). At the tibia, children with DM1 had a lower cortical porosity, pore volume, 
and pore diameter (Table 8). 
Table 7. Descriptive statistics and adjusted† group differences in bone size, density, and micro-
architecture at the radius between children and youth with type 1 diabetes (DM1) and typically 
developing children and youth (TDC) after log transformations. 
  DM1 (n=20)   TDC (n=45)         
  
Mean SD   Mean SD 
*Adj Mean 
Diff 
*95% CI of Adj 
Diff *p-value 






Table 8. Descriptive statistics and adjusted† group differences in bone size, density, and micro-
architecture at the tibia between children and youth with type 1 diabetes (DM1) and typically 
developing children and youth (TDC) after log transformations. 
Tt.Ar (mm²) 193.3 43.3   208.4 41.0 -28.3 -44.4 -12.1 0.001 
Tt.BMD (mg HA/cm³) 277.9 46.1   246.8 40.7 30.4 8.7 52.0 0.007 
ln(Ct.Ar) 3.68 0.29   3.67 0.18 -0.03 -0.12 0.06 0.488 
ln(Ct.TV) 5.88 0.29   5.87 0.18 -0.03 -0.12 0.06 0.488 
ln(Ct.BV) 5.77 0.32   5.63 0.18 0.08 -0.01 0.18 0.097 
Ct.BMD (mg HA/cm³) 771.0 62.8   690.5 52.4 65.0 37.4 92.6 <0.001 
Ct.TMD (mg HA/cm³) 811.8 55.1   762.6 35.3 35.7 15.0 56.3 0.001 
ln(Apparent Ct.Th) -0.31 0.27   -0.54 0.17 0.19 0.08 0.29 0.001 
ln(Fine Ct.Th) -0.72 0.22   -0.96 0.14 0.20 0.11 0.29 <0.001 
ln(Ct.Po) -3.3 0.5   -2.6 0.3 -0.5 -0.7 -0.3 <0.001 
Ct.Po.V (mm³) 14.3 8.4   23.0 11.8 -7.6 -12.6 -2.6 0.004 
Ct.Po.Dm (μm) 143 7.1   162 9.9 -17 -22 -12.9 <0.001 
Tb.Ar (mm²) 154.8 37.5   177.4 38.8 -32.9 -49.9 -15.9 <0.001 
Tb.BMD (mg HA/cm³) 166.0 28.8   179.1 34.4 -7.8 -23.5 7.9 0.323 
BV/TV (%) 13.8 2.4   14.9 2.9 -0.7 -2.0 0.7 0.322 
Tb.N (1/mm) 2.1 0.2   2.3 0.2 -0.1 -0.3 0.0 0.028 
Tb.Th (μm) 66 8.7   66 9.7 1 -3.5 6.0 0.606 
Tb.Sp (μm) 416 51.4   381 51.0 27 0.7 53.7 0.044 
ln(Tb.Sp.SD) -1.83 0.16   -1.94 0.21 0.07 -0.03 0.17 0.145 
Abbreviations: Tt.Ar = total bone area, Tt.BMD = total bone mineral density, Ct.Ar = cortical area, Ct.TV = cortical 
total volume, Ct.BV = cortical bone volume, Ct.BMD = cortical bone mineral density, Ct.TMD = cortical tissue 
mineral density, Ct.Th = cortical thickness, Ct.Po = cortical porosity, Ct.Po.V = cortical pore volume, Ct.Po.Dm = 
cortical pore diameter, Tb.Ar = trabecular area, Tb.BMD = trabecular bone mineral density, BV/TV = trabecular 
bone volume fraction, Tb.N = trabecular number, Tb.Th = trabecular thickness, Tb.Sp = trabecular separation, 
Tb.Sp.SD = trabecular heterogeneity. *Bonferroni adjustment for multiple comparisons. †Covariates are evaluated 
as sex (girls=1, boys=2), years from age at PHV = -1.17y, forearm muscle area = 2327.4 mm², and BMI z-score = 
0.27. 
ln(x) = natural log transformation 
  DM1 (n=20)   TDC (n=45)         
  
Mean SD   Mean SD 
*Adj Mean 
Diff 
*95% CI of Adj 
Diff *p-value 
              Lower Upper   
Tt.Ar (mm²) 682.3 107.0   673.4 115.3 -40.6 -89.8 8.7 0.104 
Tt.BMD (mg HA/cm³) 239.3 32.5   236.4 31.6 -0.8 -18.4 16.9 0.930 
Ct.Ar (mm²) 80.3 20.2   78.9 16.5 -7.1 -15.2 1.1 0.088 
Ct.TV (mm³) 723.9 182.3   711.9 149.2 -63.8 -137.5 9.8 0.088 
Ct.BV (mm³) 629.9 176.7   585.8 128.7 -30.2 -96.1 35.8 0.364 
Ct.BMD (mg HA/cm³) 757.3 73.6   719.1 42.0 14.4 -15.1 43.9 0.333 
ln(Ct.TMD) 6.70 0.08   6.67 0.04 0.00 -0.03 0.03 0.988 
ln(Apparent Ct.Th) -0.31 0.24   -0.40 0.22 0.00 -0.12 0.12 0.981 
ln(Fine Ct.Th) -0.85 0.19   -0.95 0.12 0.05 -0.04 0.13 0.267 
Ct.Po (%) 6.1 2.3   8.0 2.5 -1.8 -3.2 -0.3 0.018 
Ct.Po.V (mm³) 40.4 17.8   52.0 23.8 -15.1 -27.6 -2.6 0.018 
Ct.Po.Dm (μm) 152 7.9   163 9.2 -11 -15.8 -5.4 <0.001 
Tb.Ar (mm²) 607.9 96.4   601.5 111.3 -41.1 -90.5 8.2 0.101 
Tb.BMD (mg HA/cm³) 180.4 19.0   187.5 24.4 -5.3 -18.4 7.8 0.422 
BV/TV (%) 15.0 1.6   15.6 2.0 -0.4 -1.5 0.6 0.414 






For my secondary objective, daily minutes of VPA independently predicted the variance 
in cortical TMD (Std. β=-0.21, p=0.041), fine cortical thickness (Std. β=-0.24, p=0.024), and 
cortical pore diameter at the radius (Std. β=-0.20, p=0.019), but did not independently predict the 
variance in total bone area, total or cortical BMD, apparent cortical thickness, cortical porosity, 
pore volume, trabecular area, number, or separation (Table 9). Daily minutes of MVPA and daily 
impacts did not contribute to the overall variance in bone size, density, and micro-architecture at 
the radius or tibia. Pairwise comparisons revealed that group differences in radius bone size, 
density, cortical and trabecular micro-architecture between children with DM1 and TDC 
remained after adjusting for daily minutes of VPA, excluding trabecular separation (p=0.053) 
(Table 10). After adjusting for VPA, children with DM1 still had a lower total bone area; greater 
total BMD, cortical BMD, cortical TMD, apparent cortical thickness, fine cortical thickness; and 
a lower cortical porosity, pore volume, pore diameter, trabecular area, and number at the radius 
(Table 10). 
Table 9. Standardized β-coefficients of base model covariates and daily minutes of vigorous 
physical activity (VPA) for bone size, density, and micro-architecture at the radius in a pooled 
sample of children and youth with type 1 diabetes (DM1) and typically developing children and 
youth (TDC) after log transformations. 
Tb.Th (μm) 74 9.5   76 11.5 -3 -9.0 3.3 0.353 
Tb.Sp (μm) 416 42.7   412 61.3 -2 -33.1 29.2 0.901 
Tb.Sp.SD (μm) 174 30.8   170 37.5 -2 -21.5 17.2 0.822 
Abbreviations: Tt.Ar = total bone area, Tt.BMD = total bone mineral density, Ct.Ar = cortical area, Ct.TV = 
cortical total volume, Ct.BV = cortical bone volume, Ct.BMD = cortical bone mineral density, Ct.TMD = cortical 
tissue mineral density, Ct.Th = cortical thickness, Ct.Po = cortical porosity, Ct.Po.V = cortical pore volume, 
Ct.Po.Dm = cortical pore diameter, Tb.Ar = trabecular area, Tb.BMD = trabecular bone mineral density, BV/TV 
= trabecular bone volume fraction, Tb.N = trabecular number, Tb.Th = trabecular thickness, Tb.Sp = trabecular 
separation, Tb.Sp.SD = trabecular heterogeneity. *Bonferroni adjustment for multiple comparisons. 
†Covariates were evaluated as sex (girls=1, boys=2), years from age at PHV = -1.10y, lower leg muscle area = 
4519.9mm², and BMI z-score = 0.27.  
ln(x) = natural log transformation. 
    Std. β p-value 
Tt.Ar Sex 0.26 0.040 
  Maturity (years from aPHV) 0.58 <0.001 





  Body mass index z-score 0.01 0.919 
  ln(Daily VPA) 0.15 0.099 
  Group (DM1 and TDC) -0.30 0.001 
Tt.BMD Sex -0.02 0.907 
  Maturity (years from aPHV) -0.26 0.196 
  Forearm muscle area 0.55 0.011 
  Body mass index z-score -0.02 0.883 
  ln(Daily VPA) -0.04 0.703 
  Group (DM1 and TDC) 0.31 0.008 
Ct.BMD Sex 0.20 0.141 
  Maturity (years from aPHV) 0.46 0.008 
  Forearm muscle area -0.39 0.031 
  Body mass index z-score 0.50 <0.001 
  ln(Daily VPA) -0.09 0.345 
  Group (DM1 and TDC) 0.44 <0.001 
Ct.TMD Sex 0.19 0.168 
  Maturity (years from aPHV) 0.52 0.004 
  Forearm muscle area -0.25 0.177 
  Body mass index z-score 0.38 0.004 
  ln(Daily VPA) -0.21 0.041 
  Group (DM1 and TDC) 0.33 0.001 
ln(Apparent Ct.Th) Sex 0.15 0.304 
  Maturity (years from aPHV) 0.25 0.184 
  Forearm muscle area 0.19 0.326 
  Body mass index z-score 0.01 0.934 
  ln(Daily VPA) -0.20 0.070 
  Group (DM1 and TDC) 0.36 0.001 
ln(Fine Ct.Th) Sex 0.16 0.265 
  Maturity (years from aPHV) 0.46 0.010 
  Forearm muscle area -0.31 0.099 
  Body mass index z-score 0.25 0.059 
  ln(Daily VPA) -0.24 0.024 
  Group (DM1 and TDC) 0.44 <0.001 
ln(Ct.Po) Sex -0.10 0.444 
  Maturity (years from aPHV) -0.47 0.005 
  Forearm muscle area 0.67 <0.001 
  Body mass index z-score -0.50 <0.001 
  ln(Daily VPA) 0.07 0.476 
  Group (DM1 and TDC) -0.52 <0.001 
Ct.Po.V Sex -0.10 0.510 
  Maturity (years from aPHV) -0.47 0.011 
  Forearm muscle area 0.96 <0.001 
  Body mass index z-score -0.48 0.001 
  ln(Daily VPA) 0.01 0.945 
  Group (DM1 and TDC) -0.31 0.004 
Ct.Po.Dm Sex -0.02 0.865 
  Maturity (years from aPHV) -0.10 0.476 
  Forearm muscle area 0.34 0.025 
  Body mass index z-score -0.56 <0.001 
  ln(Daily VPA) -0.20 0.019 
  Group (DM1 and TDC) -0.66 <0.001 
Tb.Ar Sex 0.22 0.124 
  Maturity (years from aPHV) 0.49 0.005 






Table 10. Descriptive statistics of bone size, density, and micro-architecture at the radius 
between children and youth with type 1 diabetes (DM1) and typically developing children and 
youth (TDC). Adjusting† for covariates in base model, as well as daily minutes of vigorous 
physical activity (VPA) after log transformations. 
  Body mass index z-score -0.03 0.831 
  ln(Daily VPA) 0.18 0.078 
  Group (DM1 and TDC) -0.37 <0.001 
Tb.N Sex -0.36 0.032 
  Maturity (years from aPHV) -0.69 0.001 
  Forearm muscle area 0.66 0.004 
  Body mass index z-score -0.12 0.452 
  ln(Daily VPA) 0.06 0.595 
  Group (DM1 and TDC) -0.26 0.033 
Tb.Sp Sex 0.33 0.045 
  Maturity (years from aPHV) 0.72 0.001 
  Forearm muscle area -0.73 0.001 
  Body mass index z-score 0.15 0.326 
  ln(Daily VPA) -0.10 0.406 
  Group (DM1 and TDC) 0.23 0.053 
Abbreviations: Tt.Ar = total bone area, Tt.BMD = total bone mineral density, Ct.Ar = cortical area, Ct.TV = cortical 
total volume, Ct.BV = cortical bone volume, Ct.BMD = cortical bone mineral density, Ct.TMD = cortical tissue 
mineral density, Ct.Th = cortical thickness, Ct.Po = cortical porosity, Ct.Po.V = cortical pore volume, Ct.Po.Dm = 
cortical pore diameter, Tb.Ar = trabecular area, Tb.BMD = trabecular bone mineral density, BV/TV = trabecular 
bone volume fraction, Tb.N = trabecular number, Tb.Th = trabecular thickness, Tb.Sp = trabecular separation, 
Tb.Sp.SD = trabecular heterogeneity. ln(x) = natural log transformation. 
  DM1 (n=20)   TDC (n=45)         
  
Mean SD   Mean SD 
*Adj Mean 
Diff 
*95% CI of Adj 
Diff *p-value 
              Lower Upper   
Tt.Ar (mm²) 193.3 43.3   208.4 41.0 -27.1 -43.1 -11.2 0.001 
Tt.BMD (mg HA/cm³) 277.9 46.1   246.8 40.7 30.0 8.2 51.9 0.008 
ln(Ct.Ar) 3.68 0.29   3.67 0.18 -0.04 -0.13 0.05 0.434 
ln(Ct.TV) 5.88 0.29   5.87 0.18 -0.04 -0.13 0.05 0.434 
ln(Ct.BV) 5.77 0.32   5.63 0.18 0.08 -0.02 0.17 0.117 
Ct.BMD (mg HA/cm³) 771.0 62.8   690.5 52.4 63.9 36.1 91.6 <0.001 
Ct.TMD (mg HA/cm³) 811.8 55.1   762.6 35.3 33.9 13.8 54.0 0.001 
ln(Apparent Ct.Th) -0.31 0.27   -0.54 0.17 0.18 0.07 0.28 0.001 
ln(Fine Ct.Th) -0.72 0.22   -0.96 0.14 0.19 0.10 0.28 <0.001 
ln(Ct.Po) -3.3 0.5   -2.6 0.3 -0.53 -0.71 -0.34 <0.001 
Ct.Po.V (mm³) 14.3 8.4   23.0 11.8 -7.6 -12.7 -2.5 0.004 
Ct.Po.Dm (μm) 143 7.1   162 9.9 -18 -22.1 -13.5 <0.001 
Tb.Ar (mm²) 154.8 37.5   177.4 38.8 -31.6 -48.4 -14.9 <0.001 
Tb.BMD (mg HA/cm³) 166.0 28.8   179.1 34.4 -7.0 -22.7 8.7 0.375 
BV/TV (%) 13.8 2.4   14.9 2.9 -0.6 -1.9 0.7 0.374 
Tb.N (1/mm) 2.1 0.2   2.3 0.2 -0.1 -0.3 0.0 0.033 
Tb.Th (μm) 66 8.7   66 9.7 1 0.0 0.0 0.538 
Tb.Sp (μm) 416 51.4   381 51.0 26 0.0 0.1 0.053 






Abbreviations: Tt.Ar = total bone area, Tt.BMD = total bone mineral density, Ct.Ar = cortical area, Ct.TV = cortical 
total volume, Ct.BV = cortical bone volume, Ct.BMD = cortical bone mineral density, Ct.TMD = cortical tissue 
mineral density, Ct.Th = cortical thickness, Ct.Po = cortical porosity, Ct.Po.V = cortical pore volume, Ct.Po.Dm = 
cortical pore diameter, Tb.Ar = trabecular area, Tb.BMD = trabecular bone mineral density, BV/TV = trabecular 
bone volume fraction, Tb.N = trabecular number, Tb.Th = trabecular thickness, Tb.Sp = trabecular separation, 
Tb.Sp.SD = trabecular heterogeneity. *Bonferroni adjustment for multiple comparisons. †Covariates are evaluated 
as sex (girls=1, boys=2), years from age at PHV = -1.17y, forearm muscle area = 2327.4 mm²,  BMI z-score = 
0.27, and ln(VPA) =2.72. 
ln(x) = natural log transformation. 
